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Abstract 
 
Canola oil intake has been found to shorten the lifespan of stroke-prone 
spontaneously hypertensive (SHRSP) rats. Oxidative stress may be a possible 
mechanism leading to the acceleration of hypertension-related deterioration of 
organs in canola oil fed SHRSP rats. Oxidative stress leads to vascular damage, 
and plays a role in the pathogenesis of cardiovascular diseases. In vascular cells, 
NADPH oxidase is a major source of reactive oxygen species (ROS). An increase 
in ROS can result in endothelial dysfunction, which is an independent predicator 
of cardiovascular disease. The overall objectives of the thesis were to determine 
the effect of canola oil ingestion on oxidative stress in the vasculature and 
endothelial function in SHRSP rats.  
  
The study described in Chapter 3 aimed to determine if the life shortening effect 
of canola oil intake is associated with an increase in oxidative stress in SHRSP 
rats. The results found that canola oil ingestion reduced the lifespan of SHRSP 
rats compared to soybean oil following 1% NaCl loading, 85.8 ± 1.1 and 98.3 ± 
3.4 days, respectively. These results strengthen the finding that canola oil intake, 
as the sole dietary fat source, reduces the lifespan of SHRSP rats. Furthermore, 
this study also found that canola oil ingestion leads to changes in oxidative status, 
despite an improvement in the plasma lipids. In addition, NaCl loading may be 
masking the effects of canola oil in SHRSP rats.  
 
The study described in Chapter 4 examined the effect of short-term ingestion of 
canola oil in the absence or presence of salt loading on oxidative stress. The 
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results indicate that canola oil reduces antioxidant status and increases plasma 
lipids, which are risk factors for cardiovascular disease. However, canola oil in 
combination with salt intake increases malondialdehyde, a marker of lipid 
peroxidation and decreases NAPDH oxidase subunits and superoxide dismutase 
aortic mRNA expression.  
 
The study described in Chapter 5 investigated the effect of 50 days of canola oil 
intake on oxidative stress and endothelial function. The results from this study 
showed that 50 days of canola oil ingestion increases p22
phox
 and NOX2 mRNA 
expression, suggesting an increase in superoxide generation. However, canola oil 
ingestion in combination with salt leads to impaired endothelium-dependent 
vasorelaxation and reduced smooth muscle contractile function.  
 
In conclusion, the results from the thesis confirm that canola oil ingestion shortens 
the lifespan of SHRSP rats. In addition, the results have shown that canola oil 
ingestion alone leads to changes in oxidative status and plasma lipids in SHRSP 
rats. Furthermore, canola oil in combination with salt leads to endothelial 
dysfunction.  
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CHAPTER 1  
Overview and thesis rationale 
 
 
The stroke-prone spontaneously hypertensive (SHRSP) rat is a model of human 
essential hypertension and stroke, and is derived from the spontaneously 
hypertensive rat (SHR) and the Wistar-Kyoto (WKY) rat strain (Huang et al. 
1997; Ogawa et al. 2003; Okamoto et al. 1974; Tatematsu et al. 2004).  Canola oil 
ingestion, as the sole dietary fat source, has been found to shorten the lifespan of 
SHRSP rats by 15-20% following 1% NaCl loading (Huang et al. 1996 & 1997; 
Natio et al. 2003; Ogawa et al. 2003; Ohara et al. 2006; Ratnayake et al. 2000a & 
2000b). NaCl loading is used to accelerate the development of hypertension. The 
mechanism by which canola oil shortens the lifespan of SHRSP rats is still 
unknown. The concentration of phytosterols in canola oil has been suggested to be 
a contributing factor. However, conflicting results have shown no clear correlation 
between the content of phytosterols in the diet and survival time observed (Ohara 
et al. 2006; Tatematsu et al. 2004). In addition, NaCl loading may be masking the 
effects of dietary phytosterols and canola oil in the SHRSP rat. A recent study 
showed that dietary phytosterols and phytostanols increase blood pressure in 
WKY rats in the absence of NaCl loading (Chen et al. 2010). It has been proposed 
that a key mechanism leading to the shortened lifespan in SHRSP rats is via the 
acceleration of hypertension-related deterioration of organs (Natio et al. 2003; 
Ohara et al. 2006). This damage and deterioration of organs may be exacerbated 
by oxidative stress due to canola oil ingestion, which has not been examined 
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previously in SHRSP rats. Furthermore, oxidative stress may be increasing 
overtime with continued ingestion of canola oil.  
 
Growing evidence has found that oxidative stress leads to vascular damage and 
plays a critical role in the pathogenesis of cardiovascular disease (CVD) such as 
hypertension, and is elevated in SHRSP rats (Berry et al. 2001). It has been found 
that reactive oxygen species (ROS) production is increased in both experimental 
and clinical hypertension, with a decrease in the antioxidant reserve in vascular 
tissues (Touyz & Schiffrin 2004). Furthermore, in both experimental and clinical 
hypertension, ROS and oxidative stress have been found to be associated with 
end-stage organ damage (Touyz & Schiffrin 2004). ROS are produced by all cells 
within the vascular wall (endothelial, smooth muscle and adventitial cells). In the 
vasculature, nicotinamide adenine dinucleotide phosphate (NADPH) oxidase has 
been found to be the major producer of ROS (Fortuno et al. 2005). In addition, 
ROS leads to a decrease in nitric oxide (NO), resulting in endothelial dysfunction. 
Research has shown that endothelial dysfunction is an independent predicator of 
CVD (Davies 2009).  
 
The body has a highly structured antioxidant system, which protects and prevents 
oxidative damage to cellular structures (Sies 1997). Red blood cells (RBCs) have 
protective mechanisms to detoxify and scavenge ROS, and protect endothelial 
cells against free radical damage (Richards et al. 1998b). In CVD, evidence has 
shown that the activities of the antioxidant enzymes, superoxide dismutase (SOD), 
catalase and glutathione peroxidase (GPx) are reduced, with an increase in the 
markers of oxidative stress, malondialdehyde (MDA) and 8-isoprostane (Redon et 
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al. 2003; Tsuda 2011). Studies have shown that canola oil intake leads to changes 
in antioxidant status in SHR and WKY rats (Ohara et al. 2008a & 2009). In 
addition, evidence has shown a clear association between salt intake and 
hypertension (Bragulat & de la Sierra 2002). Furthermore, high salt intake has 
been shown to induce oxidative stress in salt sensitive hypertensive individuals 
(de Cavanagh et al. 2010), increase superoxide (∙O2ˉ) production in SHR 
(Kitiyakara et al. 2003) and lead to endothelial dysfunction in Sprague-Dawley 
rats (Datla & Griendling 2010).  
 
1.1 Aims  
The overall objectives of the thesis were to determine the effect of canola oil 
ingestion on oxidative stress in the vasculature and endothelial function in SHRSP 
rats. 
 
The first study aimed to determine if the life shortening effect of canola oil intake 
in SHRSP rats affects: 
(1) the antioxidant and oxidative stress markers in the circulation compared to 
soybean oil and pre-treatment  
(2) the plasma lipids compared to soybean oil and pre-treatment  
 
The second study examined the effects of short-term ingestion of canola oil in 
SHRSP rats. This study aimed to determine if 25 days of canola oil intake in the 
absence of excess dietary salt or together with salt loading effects: 
(1) the antioxidant and oxidative stress markers in the circulation 
(2) aortic mRNA expression of NADPH oxidase subunits and SOD isoforms  
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The third study aimed to determine if 50 days of canola oil intake in the absence 
of excess dietary salt or together with salt loading effects:  
(1) the antioxidant and oxidative stress markers in the circulation 
(2) aortic mRNA expression of NADPH oxidase subunits and SOD isoforms  
(3) endothelial function in SHRSP rats 
 
1.2 Research questions  
Research has found that canola oil ingestion as the sole dietary fat source shortens 
the lifespan of SHRSP rats by 15-20% following 1% NaCl loading. It has been 
proposed that a key mechanism leading to the shortened lifespan in SHRSP rats is 
via the acceleration of hypertension-related deterioration of organs (Natio et al. 
2003; Ohara et al. 2006). This damage and deterioration of organs may be 
exacerbated by oxidative stress due to canola oil ingestion. Therefore, the 
following research questions were developed:  
(1) Is the life-shortening effect of canola oil in SHRSP rats caused by an increase 
in oxidative stress and altered antioxidant status in plasma and erythrocytes? 
(2) Is the life-shortening effect of canola oil in SHRSP rats caused by endothelial 
dysfunction and enhanced aortic oxidative stress?  
 (3) Is salt loading masking the effects of canola oil-induced changes in 
antioxidant status and oxidative stress in the plasma, erythrocytes, and aorta?  
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CHAPTER 2 
Literature Review 
 
 
2.1 Cardiovascular health 
CVD is one of the leading causes of premature death in Australia and is a major 
health problem (AIHW 2011). CVD refers to conditions related to the heart and 
blood vessels, such as hypertension, stroke, atherosclerosis, myocardial infarction 
and angina. Approximately 18% (3.5 million) of Australians reported having a 
long-term CVD related condition in 2007-08, of which 11% (2.1 million) reported 
having hypertension (AIHW 2011). There are a number of risk factors that 
increase the development of CVD, and include hypertension, high blood 
cholesterol, obesity, diabetes, poor nutrition and inadequate physical activity. 
Recent research has shown that endothelial dysfunction is an early sign of CVD, 
such as hypertension and diabetes (Davies 2009). 
  
2.1.1 Endothelial and vascular smooth muscle function 
Two major components of blood vessels are endothelial cells and vascular smooth 
muscle cells (VSMCs) (Hsueh & Anderson 1992). The cellular lining of all blood 
vessels in the circulatory system is made up of endothelium. It forms a structural 
barrier between the blood stream and the underlying smooth muscle cells (Fitridge 
& Thompson 2007). Vascular homeostasis is maintained by the endothelium 
through complex interactions between the cells in the vessel wall and the lumen 
(Widlansky et al. 2003). Normal functions carried out by the endothelium to 
maintain vascular homeostasis include: maintenance of vascular tone; balancing 
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blood fluidity and thrombosis; and control of the vascular inflammatory process 
(Dworakowski et al. 2008; Widlansky et al. 2003). These functions are mediated 
by the synthesis and release of paracrine factors (nitric oxide [NO], endothelin, 
growth factors and chemotactic molecules) and the expression of surface 
molecules (Dworakowski et al. 2008; Chhabra 2009).  
 
NO is one of the most significant vasodilating substances released by the 
endothelium and plays an important role in regulating vascular tone and structure 
(Endemann & Schiffrin 2004). In the vessel wall NO is produced from L-arginine 
by endothelial nitric oxide synthase (eNOS) (Endemann & Schiffrin 2004; 
Stanevicius et al. 2003). The release of NO from the endothelium activates 
guanylyl cyclase and increases cyclic guanosine monophosphate (cGMP) 
concentrations in smooth muscles cells. This increase in cGMP concentrations 
leads to a decrease in calcium levels, which results in vasorelaxation of smooth 
muscles cells (de Champlain et al. 2004; Stanevicius et al. 2003). NO is also an 
anti-inflammatory mediator, inhibits platelet and leukocyte aggregation and 
smooth muscle cell proliferation (Fortuno et al. 2006). Mounting evidence 
indicates that oxidative stress results in a loss of NO bioactivity, resulting in 
endothelial dysfunction (Ferroni et al. 2006). Endothelial dysfunction involves 
alteration in endothelial cell function by irregular vasodilatory responses, 
enhanced generation of vasoconstricting substances, impaired control of 
inflammatory processes and increased expression of adhesion molecules (Cai & 
Harrison 2000; Chhabra 2009). 
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The endothelium produces vasoconstrictor substances such as endothelin. The 
vasoconstricting actions are balanced by the production of endothelium-derived 
relaxing factor, NO (Hsueh & Anderson 1992). The endothelium prevents the 
proliferation of smooth muscle in its basal unactivated state, through the 
production of molecules such as transforming growth factor-β (TGF β) and NO. 
When activated, cytokine/growth factor production by the unstable endothelium 
or vasoconstrictor substances leads to the proliferation of VSMCs. Thus, the 
endothelium plays an important role in regulating vascular tone and the growth of 
surrounding connective tissue (Hsueh & Anderson 1992; Limaye & Vadas 2007).  
 
VSMCs make up the medial layer of blood vessels and in normal physiology they 
have a differentiated, contractile phenotype (Clempus & Griendling 2006). 
VSMCs can undergo hypertrophy and lose their specialised form and function 
under pathological conditions. With pathological stimuli, VSMCs produce 
inflammatory cytokines, excess extracellular matrix, and divide and migrate 
towards the intima (Clempus & Griendling 2006). ROS have been associated with 
all the changes that occur to VSMCs in pathological conditions (Clempus & 
Griendling 2006).  
 
2.2  ROS, oxidative stress and endogenous antioxidants in the 
vasculature 
Molecular oxygen is vital for cellular metabolism and for energy production. 
However, during the reduction of molecular oxygen to water, ROS are generated 
(Izawa et al. 1996). The body has a highly structured antioxidant defence system 
that protects the cells from oxidative damage caused by ROS (Clarkson & 
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Thompson 2000). An imbalance in excess ROS generation and limited antioxidant 
protection results in oxidative stress (Sies 1997). Stable concentrations of these 
oxidants are needed, as they may engage in intracellular signalling. However, an 
immoderate increase of these oxidants leads to oxidative damage to cellular 
structures such as lipids, proteins and DNA (Turrens 2003).   
 
ROS are produced by all cells within the vascular wall (endothelial, smooth 
muscle and adventitial cells) and in both vascular physiology and 
pathophysiology; ROS plays a central role (Fortuno et al. 2005; Touyz & Briones 
2011; Zalba et al. 2001). Growing evidence suggests that in normal physiology, 
ROS play an important role in vascular and cardiac cell function, and regulate 
processes involved in gene control and cell to cell interactions (Lyle & Griendling 
2006; Zalba et al. 2005). ROS play a role in intracellular signalling that mediates 
vascular cell growth and survival, differentiation and apoptosis (Berry et al. 2001; 
Griendling & Fitzgerald 2003). In addition, ROS control numerous classes of 
genes, such as antioxidant enzymes (SOD and catalase), adhesion molecules, 
chemotactic molecules and vasoactive substances (Griendling & Fitzgerald 2003). 
In vascular pathophysiology, the upregulation of adhesion molecules and 
chemotactic molecules by ROS promote adhesion and attract the migration of 
monocytes into the vessel wall (Griendling & Fitzgerald 2003). An excess of ROS 
activity and limited antioxidant protection results in oxidative stress, and as a 
consequence oxidative damage occurs to cellular structures (Berry et al. 2001). 
Increased ROS production in the vasculature under pathological conditions leads 
to vascular remodelling, endothelial dysfunction, increased contractility, lipid 
peroxidation and inflammation (Touyz & Briones 2011).    
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In cells there are several enzymatic sources of ROS which include: mitochondrial 
respiration, xanthine oxidase, NADPH oxidase, uncoupled nitric oxide synthase, 
lipoxygenases and cyclooxygenases (Jiang et al. 2004). However, in the 
vasculature NADPH oxidase has been found to be the major producer of ROS 
(Fortuno et al. 2005). The most significant ROS in vascular cells are superoxide 
(∙O2ˉ), hydrogen peroxide (H2O2) and peroxynitrite (ONOO
-
) (Figure 2.1). During 
oxidative stress, when ∙O2ˉ
 
is formed simultaneously with NO, they react with 
each other to form ONOO
-
. ONOO
- 
is a highly reactive molecule and is an 
important mediator of lipid peroxidation and protein nitration (Sachidanandam et 
al. 2005). ONOO
- 
can act as a NO antagonist and affect its vasodilatory function. 
This reaction decreases NO bioavailability in the blood vessel (de Champlain et 
al. 2004). ∙O2ˉ is produced when oxygen is reduced by one electron. This oxygen 
radical is the ancestor of the majority of ROS and an intermediate in the oxidative 
chain reactions (Turrens 2003). In the absence of immediate NO availability, ∙O2ˉ 
becomes altered either through a reaction or spontaneously to form H2O2 by SOD.  
H2O2 is then converted to water (H2O) by either catalase or GPx (de Champlain et 
al. 2004). Potent enzymatic and non-enzymatic antioxidants which are present 
both at the intracellular and extracellular levels inactivate ROS and help protect 
the cells against oxidative stress (de Champlain et al. 2004).        
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Figure 2.1: ROS and enzymatic antioxidants in vascular cells 
(Griendling & Fitzgerald 2003).   
 
  
2.2.1 NADPH oxidase  
NADPH oxidase is a major source of ROS in vascular cells and is involved in 
endothelial dysfunction, activation and redox signalling (Dworakowski et al 2008; 
Wassmann et al. 2004). ROS derived from NADPH oxidase has been associated 
with regulating vascular tone by directly modulating vasodilation or indirectly by 
reducing NO bioavailability through the formation of ONOO
- by ∙O2ˉ (Paravicini 
& Touyz 2008). NADPH oxidase is an enzymatic complex that uses NADPH or 
NADH to catalyse ∙O2ˉ production by the one electron reduction of oxygen as the 
electron donor (Paravicini & Touyz 2008; Touyz & Schiffrin 2004):   
   2O2 + NAD(P)H               2∙O2ˉ + NAD(P)H + H
+
 
NADPH oxidase is functionally active within all the layers of the vessel wall: in 
the endothelium, the media and the adventitia (Touyz & Schiffrin 2004). NADPH 
oxidase is activated by many factors such as cytokines, shear stress, growth 
13 
 
factors, hypoxia-reoxygenation and G-protein coupled receptor agonists (Frey et 
al. 2009).  
 
NADPH oxidase was originally described in phagocytes and is made up of a 
membrane bound cytochrome b558 reductase domain, three cytosolic subunits 
(p47
phox
, p67
phox
, and p40
phox
) and a regulatory G-protein (Rac) (Figure 2.2). The 
cytochrome b558 domain is made up of two subunits: a small α-subunit, p22phox 
and a large ß-subunit, gp91
phox
 (Nox2). The p22
phox 
subunit is bound to the 
catalytic gp91
phox
 subunit (Clempus & Griendling 2006; Jiang et al. 2004). 
Gp91
phox
 contains binding sights for NADPH, molecular oxygen, heme and flavin 
groups to allow electron transport between the two subunits. On stimulation, 
p47
phox
 becomes phosphorylated and the cytosolic subunits form a complex which 
is then translocated to the membrane bound cytochrome b558. The enzyme 
becomes active and electrons are transferred from the substrate to O2, forming 
∙O2ˉ (Dworakowski et al. 2008; Fortuno et al. 2005; Lyle & Griendling 2006; 
Paravicini & Touyz 2008).   
 
In nonphagocytic cells, several gp91
phox
 homologues (referred to as the Nox 
family) have been identified, each encoded by different genes. These genes are 
expressed in many tissues and mediate diverse biological functions (Dworakowski 
et al. 2006; Paravicini & Touyz 2008). The family consists of seven members: 
Nox1, Nox2 (previously termed gp91
phox
), Nox3, Nox4, Nox5, Duox1 and Duox2 
(Paravicini & Touyz 2008). Nox1 is expressed in VSMCs as well as in epithelia; 
Nox2 is expressed in endothelial cells, cardiomyocytes and fibroblasts; Nox4 is 
expressed in many tissues such as endothelial cells, VSMCs, cardiomyocytes, 
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fibroblasts and skeletal muscle and Nox5 is found in lymphoid tissues, testis and 
pancreas (Dworakowski et al. 2006; Paravicini & Touyz 2008).     
 
In vascular cells all the subunits present on phagocytic NADPH oxidase have 
been identified, including p47
phox
, p67
phox
 and Nox2, Nox1, Nox4 and Nox5. 
Many studies have found that p22
phox
 is present in all NADPH oxidase complexes 
and is required by all Nox enzymes for activity, except Nox5 (Clempus & 
Griendling 2006; Fortuno et al. 2005). In all VSMCs p22
phox
 is expressed while 
the gp91
phox
 homologue present is Nox1, Nox2, Nox4 and/or Nox5. The 
distribution of the gp91
phox
 homologues in VSMCs is tissue and species specific 
(Clempus & Griendling 2006). Nox1, Nox 4 and p47
phox
 have been shown to be 
coexpressed in rat aortic VSMCs, whereas in humans all the major subunits 
including gp91
phox
 are present in arteries (Touyz & Schiffrin 2004).    
 
In CVD, both vascular and phagocytic NADPH oxidase play a significant role in 
the production of ∙O2ˉ, which may result in the infiltration of monocytes and 
lymphocytes in cardiovascular tissues (Fortuno et al. 2005). This is supported by 
studies in hypertensive patients showing an increase in ∙O2ˉ production derived by 
phagocytic NADPH oxidase. In adult SHR, which had endothelial dysfunction 
and vascular wall hypertrophy, there was an enhanced production of O2ˉ derived 
by NADPH oxidase. This was associated with the upregulation of p22
phox
 mRNA 
expression in the aorta (Zalba et al. 2001).    
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Figure 2.2: Structure of the NADPH oxidase complex (Ray & Shah 
2005)  
 
 
2.2.2 Antioxidant defence system against ROS 
Antioxidants provide protection against ROS and oxidative damage through 
preventing the formation of ROS, to intercept any further deleterious reactions of 
damaging species once formed and to repair damage that has occurred (Sies 
1997).  
 
2.2.2.1 Enzymatic antioxidants 
The major enzymatic antioxidants include SOD, catalase and GPx (Figure 2.1) 
(Paravicini & Touyz 2008). In vascular cells, SOD is a major cellular antioxidant 
that provides defence against ∙O2ˉ, by converting ∙O2ˉ to O2 and H2O2. Three 
different SOD isoforms have been identified: mitochondrial SOD (MnSOD, 
16 
 
SOD2), the cytosolic copper/zinc-containing SOD (CuZn-SOD, SOD1) and 
extracellular SOD (eSOD, SOD3). The main vascular SOD is eSOD and is 
produced and secreted by VSMCs. In the vascular extracellular matrix, it attaches 
to glycosaminoglycans on the endothelial cell surface (Paravicini & Touyz 2008; 
Wassmann et al. 2004). Within the vascular interstitium, eSOD plays an essential 
role in regulating oxidant status (Wassmann et al. 2004).    
 
GPx reduces hydrogen peroxide and lipid peroxides to water and lipid alcohols, 
respectively, by oxidising reduced glutathione (GSH) to glutathione disulfide 
(GSSG):  
H2O2 + 2GSH                                    GSSG + 2H2O 
In the absences of sufficient GPx activity or GSH levels, H2O2 and lipid peroxides 
are not detoxified and can be converted to hydroxyl radicals and lipid peroxyl 
(Wassmann et al. 2004). In low-level oxidative stress, the GPx/GSH system is 
considered to be a major defence (Paravicini & Touyz 2008; Wassmann et al. 
2004).     
 
Catalase is primarily located in cellular peroxisomes and to some degree in the 
cytosol (Paravicini & Touyz 2008; Wassmann et al. 2004). It breaks down H2O2 
to water and molecular oxygen:   
 
 2H2O2               2H2O + O2 
∙O2ˉ radicals are indirectly detoxified by the removal of H2O2 by catalase as ∙O2ˉ 
is converted into H2O2 by SOD (Wassmann et al. 2004). Catalase is also able to 
react with organic peroxides and hydrogen donors and convert them into water 
GPx 
Catalase 
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and organic alcohols. In high level oxidative stress catalase is very efficient and 
protects the cells from H2O2 made within the cell (Wassmann et al. 2004). In 
situations of limited concentrations of glutathione and decreased GPx activities, 
catalase is very important in providing protection (Paravicini & Touyz 2008). 
Also, catalase plays an important role in the development of tolerance to oxidative 
stress (Wassmann et al. 2004).  
 
2.3 Erythrocytes antioxidant defence against oxidative stress  
Erythrocytes or RBCs are under constant exposure to ROS and oxidative stress 
due to their role in transporting oxygen and carbon dioxide, and their increased 
content of heme iron (Cimen 2008). Haemoglobin (Hb) is the source of ROS in 
RBCs, which undergoes autoxidation to generate ∙O2ˉ (Cimen 2008). In 
biochemical reactions, iron is the most important and abundant transition metal. 
Iron binds oxygen and is also involved in several fundamental oxidation-reduction 
reactions (Cimen 2008). The haem iron must be maintained in the reduced state in 
order to bind oxygen. Hb can become non-functional if this mechanism fails. The 
consequence of this process results in iron release from Hb, which leads to 
methaemoglobin (metHb) formation. Lipid peroxidation and haemolysis can 
accompany iron release if RBC GSH is depleted (Cimen 2008).          
 
In cells and tissues, oxidative stress occurs when ROS levels exceed antioxidant 
protection. In several diseases, the oxidant/antioxidant balance can become altered 
in RBCs. Within RBCs, protective mechanisms exist to detoxify and scavenge 
ROS, and protect endothelial cells against free radical damage (Richards et al. 
1998b). RBCs have an antioxidant system made up of enzymatic and non-
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enzymatic antioxidants that help prevent oxidative damage (Cimen 2008). The 
enzymatic antioxidants present in RBCs include SOD, catalase, GPx and NADH-
metHgb reductase. As mentioned earlier, SOD converts ∙O2ˉ to O2 and H2O2. 
Cytosolic CuZn-SOD is the major form of SOD present in RBCs. The abundance 
of CuZn-SOD protects RBCs from ROS by scavenging free radicals, which 
prevents metHgb generation (Cimen 2008). Catalase and GPx are two enzymes 
present at high levels within RBCs that break down H2O2. GPx is very important 
in dealing with endogenous H2O2 generated by Hb autoxidation, while catalase 
plays an important role in dealing with increased H2O2 exposed to RBCs (Cimen 
2008). Previous research has shown an inverse relationship between erythrocyte 
GPx activity and the incidence of CVD (Blankenberg et al. 2003). It has been 
shown that in patients with coronary artery disease the activity of RBC GPx is 
significantly reduced (Blankenberg et al. 2003). The reduced activity of RBC GPx 
may identify the patients who are at risk of cardiovascular events (Blankenberg et 
al. 2003).    
 
RBCs consist of several non-enzymatic antioxidants, which include vitamin E, C, 
A and GSH (Cimen 2008). Vitamin E acts as an antioxidant in the lipid phase 
whereas vitamin C acts in the aqueous phase. Vitamin C reduces ∙O2ˉ and lipid 
peroxyl radicals, and has been shown to have a protective role against 
peroxidation of membrane lipids in RBCs and tocopherols from t-
butylhydroperoxide (Cimen 2008). Vitamin E is one of the most distributed 
antioxidants within the body. Evidence suggests that RBC vitamin E 
concentrations are more suitable to evaluate the risk of atherosclerosis (Simon et 
al. 2001). It has been found that reduced levels of RBC vitamin E are involved in 
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the early phases of atherosclerosis (Bonithon-Kopp et al. 1997). In vitro, vitamin 
E has protective effects on the early stages in the atherosclerotic process, such low 
density lipoprotein (LDL) oxidation, leukocyte adhesion to endothelial cells, 
VSMC migration and proliferation and platelet aggregation (Simon et al. 2001). 
Vitamin E and C work together to prevent lipid peroxidation in membranes and 
plasma lipoproteins. In RBCs, GSH is the most prominent non-enzymatic water 
soluble antioxidants present (Carroll et al. 2006). It can protect vital proteins such 
as spectrin, as the oxidation of spectrin can lead to membrane stiffness (Cimen 
2008). GSH can directly scavenge oxygen radicals and can act as a substrate for 
GPx during the detoxification of H2O2. It has been shown that GSH provides 
protection to cells against damage induced by ROS and oxidative stress (Cimen 
2008). Vitamin E and GSH are able to prevent the oxidation of the iron haem 
group on the Hgb molecule and on the RBC membrane (Richards et al. 1999a). 
 
RBCs can provide protective mechanisms against oxidative damage to endothelial 
cells. It has been shown that RBCs are able to take up ∙O2ˉ through an ion channel 
present within the membrane (Richards et al. 1998b). In vitro, it has been 
demonstrated that damage to endothelial cells is initiated by neutrophils that have 
been activated with phorbol myristate acetate (PMA), a process linked to the 
release of ROS. In vivo, endothelial cell injury may also take place due to the 
production of ROS by neutrophils. Richards et al. (1998b) incubated RBCs and 
neutrophils that were activated with PMA with radiolabelled human umbilical 
vein endothelial cells. Cells were treated with inhibitors of either ∙O2ˉ transport (4-
acetamido-4’-isothiocyano-2,2’ disulphonic acid stilbene) or GSH system (N-
ethylmaleimide). When ∙O2ˉ transport or the GSH system was inhibited, 
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endothelial cell damage increased. Therefore, RBCs may provide protection to 
endothelial cells and other tissues against oxidative damage via importing ∙O2ˉ 
through an ion channel present within the membrane and deactivating them by the 
antioxidant system present Richards et al. (1998b).       
 
Several cell types are able to synthesis and release NO, which include endothelial 
cells, neutrophils, macrophages and platelets (Chen & Mehta 1998). RBCs have 
been recognised to inactivate free NO. Released NO from the endothelium is 
taken up by RBCs and inactivated by oxyhaemoglobin. During this process, Hgb 
is changed to methaemoglobin and NO is changed to nitrate, which is removed by 
the kidneys (Richards et al. 1998a). Evidence suggests that NOS is present within 
RBCs and they are able to synthesis their own NO. RBC-derived NO has been 
shown to provide cardioprotective effects in isolated rat heart from ischemia-
reperfusion injury (Chen & Mehta 1998). RBC-derived NO may be significant 
within vascular physiology as it may help regulate vascular tone and platelet 
aggregation (Chen & Mehta 1998).         
 
2.4 Oxidative stress, hypertension and endothelial dysfunction  
Growing evidence has found that oxidative stress leads to vascular damage and 
plays a critical role in the pathogenesis of CVD such as hypertension (Berry et al. 
2001). It has been found that ROS production is increased in both experimental 
and clinical hypertension, with a decrease in the antioxidant reserve in vascular 
tissues (Touyz & Schiffrin 2004). In both experimental and clinical hypertension, 
ROS and oxidative stress have been found to be associated with end-stage organ 
damage (Touyz & Schiffrin 2004). An increase in ROS activity contributes to the 
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impaired regulation of physiological processes within the vascular wall, which 
leads to structural and functional changes observed in hypertension (Figure 2.3) 
(Zalba et al. 2001). Endothelial dysfunction and VSMC hypertrophy are two 
characteristic changes that take place within the vascular wall in hypertension 
(Zalba et al. 2001).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.3: Functional and structural consequences of ROS in 
hypertension (adapted from Fortuno et al. 2005).    
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In genetic models of hypertension, such as SHR and SHRSP rats, the production 
of ∙O2ˉ derived by NADPH oxidase is increased in the aorta, mesenteric arteries 
and kidneys. This is linked with the increased expression of NADPH oxidase 
subunits, mainly p22phox and p47phox (Touyz & Schiffrin 2004). It has been 
found that vascular ∙O2ˉ production was greater in SHRSP rats when compared 
with WKY rats; and that superoxide production and NADPH oxidase is increased 
in cultured VSMCs of SHR (Berry et al. 2001; de Champlain et al. 2004). In 
human hypertension, there is a decrease in NO bioavailability and enhanced 
oxidative stress levels (Ferroni et al. 2006). In hypertensive patients, VSMCs from 
resistance arteries have increased ROS generation, and this increase is linked to 
NADPH oxidase (Paravicini & Touyz 2008). As well as increased ROS 
production, hypertensive patients have reduced levels of antioxidant. In newly 
diagnosed untreated hypertensive patients, the levels of the antioxidant vitamins, 
A, C and E have been found to be reduced compared to the control subjects in 
plasma (Paravicini & Touyz 2008). It has been reported that low plasma 
concentrations of vitamin C can predict an increased risk of cardiovascular 
disease (Berry et al. 2001). The activities and content of the antioxidant enzymes, 
SOD, catalase and GPx have been found to be reduced both in whole blood and 
peripheral mononuclear cells (Redon et al. 2003). In addition, lipid peroxidation is 
a major consequence of oxidative stress. 8-isoprostane and MDA are two 
biomarkers of lipid peroxidation, which are elevated in CVD (Block et al. 2008). 
Evidence has shown that the concentration of plasma 8-isoprostane and whole 
blood MDA are elevated in subjects with hypertension compared with 
normotensive subjects (Redon et al. 2003; Tsuda 2011). The increase in oxidative 
stress and reduced levels of antioxidants disrupts the anti-oxidative metabolism in 
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blood and circulating mononuclear cells. This may affect the functioning of 
endothelial cells and contributes to the development of CVD (Redon et al. 2003). 
In both animal models and in human hypertension improvement in vascular 
function and structure, prevention of organ damage and reduced blood pressure 
occurs following antioxidant treatment (Touyz & Schiffrin 2004). Several studies 
have shown that treatment with antioxidant vitamins or SOD mimetics reduce or 
prevent the development of hypertension and related organ damage (Paravicini & 
Touyz 2008). Also, in hypertensive animals, treatment with antioxidants or agents 
that inhibit the production of ∙O2ˉ, reduces and prevents blood pressure elevation, 
supporting the concept that ∙O2ˉ contributes to the pathogenesis of hypertension 
(Touyz & Schiffrin 2004; Zhou et al. 2006).  
 
Furthermore, many interventional and epidemiological studies have shown a clear 
association between salt intake and hypertension (Bragulat & de la Sierra 2002). 
Evidence has shown that high salt intake can induce oxidative stress in salt 
sensitive hypertensive individuals and in Dahl salt sensitive rats (de Cavanagh et 
al. 2010). A recent study by de Cavanagh et al. (2010) found an increase in ∙O2ˉ 
production in aortic and renal arteries in SHR following 1.5% NaCl loading.  
Furthermore, it has been shown that salt intake in Sprague-Dawley rats lead to an 
increase in O2ˉ production (Kitiyakara et al. 2003). This was accompanied by an 
increase in renal activity and mRNA expression of NADPH oxidase, and a 
decrease in CuZn-SOD and MnSOD mRNA expression (Kitiyakara et al. 2003). 
In addition, high salt intake resulted in an increase in vascular O2ˉ production in 
apoE-deficient mice, a mouse model of atherosclerosis (Ketonen et al. 2005).    
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Increased ROS activity in the vasculature can lead to a decrease in NO 
bioavailability and impaired endothelium-dependent vasorelaxation, which results 
in endothelial dysfunction (Berry et al. 2001; Datla & Griendling 2010; Zalba et 
al. 2001). Evidence suggests that endothelial dysfunction is associated with 
hypertension (Ferroni et al. 2006). An excess of vascular ROS generation or 
reduced levels of antioxidants to prevent ROS metabolism has recently been 
associated in the pathogenesis of endothelial dysfunction in SHRSP rats (Ulker et 
al. 2003). Studies have shown an association between high salt intake and 
endothelial dysfunction (Bragulat & de la Sierra 2002). Evidence has shown that 
in Sprague-Dawley rats, high salt intake leads to endothelial dysfunction by 
reducing the concentration of NO and eNOS activity (Datla & Griendling 2010). 
In addition, studies suggest that high salt intake and salt sensitivity are associated 
with endothelial dysfunction in essential hypertensive individuals (Bragulat & de 
la Sierra 2002).  
 
2.4.1 Assessment of endothelial function  
Endothelial function can be measured by assessing the vasodilating response to 
physical or pharmacological stimuli such as shear stress, acetylcholine (ACh), 
bradykinin, substance P and serotonin (Perticone et al. 2001; Widlansky et al. 
2003). Each agonist acts via a membrane receptor, with signal transduction 
functioning via G proteins (Perticone et al. 2001). In humans, endothelial function 
can be assessed in coronary arteries angiographically by Doppler flow 
measurements during the infusion of ACh or increased blood flow (Endemann & 
Schiffrin 2004; Widlansky et al. 2003). In healthy individuals, the response to 
these stimuli is by the endothelium releasing vasodilator substances, specifically 
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NO. It has been found that coronary and peripheral endothelial dysfunction 
predicts long term progression of atherosclerosis and CVD events in patients 
(Perticone et al. 2001). Endothelial function can be measured in the forearm 
resistance arteries via blood flow measurements using venous occlusion 
plethysmography. This method involves intra-arterial infusion of agonists such as 
ACh via a catheter in a dose response manner (Perticone et al. 2001; Widlansky et 
al. 2003). Endothelial function can also be assessed in vitro from isolated thoracic 
aortic rings. The endothelium-dependent and -independent vasodilating responses 
to ACh and sodium nitroprusside (SNP) respectively, are measured in a dose 
response manner in the presence of a submaximal contraction to norepinephrine 
(Martinez-Revelles et al. 2008).  
   
2.5 Stroke-prone spontaneously hypertensive (SHRSP) rat model 
The SHRSP rat was first established by Okamoto et al. in 1974. It is a model of 
human essential hypertension and stroke, and is derived from the SHR and WKY 
rat strains. In 1962 and 1963, the SHR colony was produced by selective 
inbreeding of WKY rats. Further breeding continued from this colony, and an 
inbred strain of SHR was obtained in 1969 (Okamoto et al. 1974). The occurrence 
of stroke in SHR was observed and mating was carried out amongst the substrains 
and generations. The offspring of which one or both parents developed stroke 
spontaneously were maintained. Stroke-prone rats were obtained after successive 
selective breeding in 1974 (Okamoto et al. 1974). The SHRSP rat strain showed 
an increase in blood pressure from a young age (around 5 weeks of age) and 
severe hypertension of around 240-250 mmHg (from 15 weeks of age) (Okamoto 
et al. 1974). The initial signs of stroke and hypertension encephalopathy were 
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observed in the rats, and included: hyperirritability, excitement (piloerection), 
behavioural and psychological depression (hyporesponsiveness, hypokinesis and 
hypotonia) and motion disturbances (Okamoto et al. 1974). After initial symptoms 
of stroke or hypertension were observed, the rats died from stroke within a few 
days to 24 weeks. Brain lesions were usually located in the cortical or subcortical 
areas of the optical, frontal and medial areas of the telencephalon. However, in 
some rats lesions were found in the basal ganglia (Okamoto et al. 1974).  In 
addition, the incidence of stroke was greater in males than in females. Males 
showed rapid development of severe hypertension in contrast to females from a 
younger age (Okamoto et al. 1974).    
 
The SHRSP rat model has been extensively used to investigate the effects of 
numerous antihypertensive agents as potential preventive effects against stroke 
and mortality (Richer et al. 1997). Agents such as angiotensin I-converting 
enzyme inhibitors and angiotensin II AT1-receptor blockers have shown to be 
very effective (Richer et al. 1997). The beneficial effects of these agents include 
the prevention of fibrinoid necrosis formation in cerebral arterioles and the 
limitation of blood pressure rise (Richer et al. 1997). Also, losartan, an 
angiotensin II AT1 receptor antagonist has shown to prevent stroke and improve 
endothelial cell and cerebral artery’s smooth muscle functions in SHRSP rats 
(Vacher et al. 1996). In addition, the SHRSP rat is a model of human insulin 
resistance (James et al. 2001). It is characterised by impaired fatty acid 
metabolism and decreased insulin-mediated glucose removal in isolated 
adipocytes (James et al. 2001). Amongst the common rat strains, the SHRSP rat 
strain develops the highest blood pressure. At 5 weeks of age SHRSP rats are 
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hypertensive, and in males the systolic blood pressure increases to at least 250 
mmHg compared to the blood pressure in SHR which rises to 200 mmHg 
(Doggrell & Brown 1998), and in WKY rats it is under 150 mmHg (Yamori & 
Horie 1977). Low protein and high-salt intake have been suggested as high risk 
factors for this animal model, which are also suggested for human apoplexy 
(Huang et al. 1997). High-salt intake is associated with increased blood pressure 
(Flegel & Magner 2009). SHRSP rats have a deficiency of cholesterol in blood 
and in cell membranes. Thus, they have weak and more fragile cell membranes 
than other rat strains (Ratnayake et al. 2000b). Dietary salt loading accelerates the 
development of hypertension and stroke. The intake of fibre, calcium, fish oil or 
cholesterol reduces the adverse effects of salt loading (Ratnayake et al. 2000b). 
SHRSP rats live to around 52-64 weeks old (early to mid-adulthood) or around 
14-20 weeks old following salt loading, compared to SHR and WKY which live 
to around 2  and 3 years, respectively (Doggrell & Brown 1998). 
 
2.5.1 Canola oil intake and SHRSP rats 
Evidence has shown that higher intakes of saturated and trans fats are associated 
with an increased risk of CVD, whilst higher intakes of monounsaturated and 
polyunsaturated fats, such as canola oil reduce the risk (Tanasescu et al. 2004). 
Previous studies using this animal model have investigated the effects of 
vegetable oils such as canola oil on lifespan and physiological changes. In 1974, 
through selective plant breeding a new rapeseed variety was released that 
contained low erucic acid and glucosinolate contents, and was renamed canola oil 
(also referred to as double low rapeseed oil) (Tatematsu et al. 2004). Oil from 
traditional rapeseed contained erucic acid and thyrotoxic sulphur compounds 
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derived from glucosinolates, which are two anti-nutritional factors. Euric acid is 
an omega-9 monounsaturated fatty acid and high exposure levels have been 
associated with myocardial lipidosis and heart lesions in Sprague-Dawley rats 
(FSANZ 2003). Glucosinolates are organic compounds containing sulphur and 
nitrogen, which affects the taste and quality of the oil, and is responsible for the 
sharp taste and the low palatability of the oil (Mailer & Wratten 1985). Canola oil 
has a high content of oleic acid (55-60%) and a low content of saturated fatty 
acids (SFA) (6-7%). In addition, it provides a low ratio of linoleic to linolenic 
acids (2:1) and is a good source of α-linolenic acid (7-10%) (Tatematsu et al. 
2004). It contains a slightly higher level of sulphur compounds compared to other 
vegetable oils.   
 
In SHRSP rats, ingestion of canola oil as the sole dietary fat source (added at 10 
wt/wt% to standard rat chow) has been reported to shorten life span compared to 
soybean oil or perilla oil (Table 2.1) (Huang et al. 1996 & 1997; Natio et al. 2003; 
Ogawa et al. 2003; Ohara et al. 2006; Ratnayake et al. 2000a & 2000b). It has 
been found to shorten the lifespan of SHRSP rats by 15-20% under 1% NaCl 
loading (Ratnayake et al. 2000b). NaCl loading is used as it accelerates the 
progression of hypertension within these animals. Even without NaCl loading, 
canola oil was found to shorten the life span of SHRSP rats compared to soybean 
oil, 254 ± 12 and 416 ± 16 days, respectively (Huang et al. 1997). The life 
shortening effect of canola oil has only been observed in SHRSP rats and has not 
been carried out in any other rat strains such as the SHR and WKY rats, to 
determine whether the effects are the same. Possible contributing factors within 
canola oil have been examined, which include the fatty acid, the sulphur and the 
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phytosterol composition of canola oil. Studies have shown that the sulphur and 
fatty acid composition of canola oil does not appear to cause the shortened life 
span (Miyazaki et al. 1998; Ratnayake et al. 2000a). A study by Ohara et al. 
(2006) tried to fractionate the causative(s) in canola oil by super gas extraction 
technique. Three different fractions were obtained: 180-bar, 350-bar and residue 
fraction during the extraction of canola oil. SHRSP were fed 10 wt/wt% soybean 
oil, canola oil, 180-bar fraction, 350-bar fraction or residue fraction. The survival 
times were significantly shorter in the canola oil, 350-bar fraction and the residue 
fraction groups. In the kidney, chronic nephropathy was common in the canola oil 
and all the fraction groups, and cerebral necrosis was found in the residue group. 
However, the fraction containing the causative(s) was not found. This has been 
the only published study that has carried out fractionation work on canola oil to 
identify the possible causative(s) contributing to the shortened life span observed 
in SHRSP rats. On the other hand, a recent study by Ohara et al. (2009) found that 
the canola oil and interesterified canola oil mimic (consisting of safflower oil, 
flaxseed oil and erucic acid) diets elevated blood pressure, increased plasma 
lipids, increased hepatic activities of glucose-6-phospate dehydrogenase (G6PD), 
reduced platelets and induced kidney abnormalities in WKY rats. The fatty acid 
composition unique to canola oil appears to affect the pathophysiology of the rat. 
However, the fatty acid composition is not asserted to be the direct causative of 
the life shortening effect of canola oil (Ohara et al. 2009).   
 
Furthermore, the concentration of phytosterols in canola oil has also been 
suggested to be a contributing factor. A previous study carried out by Ratnayake 
et al. (2000b) found that the groups containing the added phytosterols and the 
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canola oil group had significantly reduced lifespan compared to the soybean oil 
group. They also found that the RBC membrane deformability index was 
significantly higher in the canola oil group and in the groups with the added 
phytosterols indicating an increase in membrane fragility.  Another study found 
the addition of phytosterols to soybean oil caused an increased in systolic blood 
pressure and promoted the onset of stroke. However, a fivefold increase of 
phytosterols was needed to produce the same effects as canola oil (Ogawa et al. 
2003). The same study also found that intestinal mRNA expression of Abcg5 and 
Abcg8, which are genes associated with the selective transport of dietary sterols in 
the intestine were decreased in SHRSP and WKY rats compared with Wistar rats. 
This may be partly responsible for the early onset of stroke in these animals 
(Ogawa et al. 2003). However, conflicting results have shown no clear correlation 
between the content of phytosterols in the diet and tissues and survival time 
observed (Ohara et al. 2006; Tatematsu et al. 2004). In addition, NaCl loading 
may mask the effects of dietary phytosterols and canola oil in the SHRSP rat. A 
recent study showed that dietary phytosterols and phytostanols increase blood 
pressure in WKY rats in the absence of NaCl loading (Chen et al. 2010).  
 
Moreover, recent studies suggest that one of key mechanisms leading to the 
shortened life span in SHRSP rats is via the acceleration of hypertension-related 
deterioration of organs (Natio et al. 2003; Ohara et al. 2006). An increase in blood 
pressure  and enhanced Na
+
, K
+ 
-ATPase activity  have been reported as a result of 
canola oil ingestion, and may promote the deterioration of organs (Natio et al. 
2000c & 2003). Other hypertension-related conditions induced by canola oil 
ingestion in SHRSP rats include tissue lesions in the heart and kidney, as well 
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enhanced tension development in isolated aortic rings after 4 weeks of ingestion 
(Natio et al. 2000c). Furthermore, as mentioned in section 4.0, evidence suggests 
that oxidative stress is involved in the pathogenesis of hypertension and is 
elevated in SHRSP rats. The damage and deterioration of organs may be 
exacerbated by oxidative stress due to canola oil intake, which has not been 
examined previously in SHRSP rats.  
 
Evidence has shown that in WKY rats, the activity of hepatic G6PD was 
increased, along with an increase in blood pressure and plasma lipids, and the 
activities of catalase and SOD were reduced in the canola oil fed group compared 
to the control group (Natio et al. 2000d). It is well established that ROS interacts 
with endothelial NO, thus decreasing the vasodilating response of the blood 
vessel. The increase in blood pressure in the canola oil group may be due to the 
reduced endothelium-dependent vasodilation mechanism of the blood vessel, as 
the activities of catalase and SOD are decreased (Natio et al. 2000d). However, a 
study found that in SHR and WKY rats the endothelium-dependent and 
endothelium-independent vasodilating responses to ACh and SNP, respectively, 
were not different between the canola oil and soybean oil groups, despite an 
increase in blood pressure (Natio et al. 2000b). In addition, vascular lesions in the 
heart and kidney were observed in the canola oil fed SHR and WKY rats (Natio et 
al. 2000a; Ohara et al. 2008a). A recent study by Ohara et al. (2008a) found 
increased plasma lipids and increased G6PD activities in the liver and 
erythrocytes of canola fed SHR, as well as increased abundance of 
cyclooxxygenase-2 (COX-2) through immunohistochemical staining. The results 
imply that canola oil ingestion brings about hyperlipidemia in these animals, and 
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the increased G6PD may serve as a NADPH provider.  The study also found an 
increase RBC GSH and glutathione reductase, with a decrease in the activity of 
RBC GPx. Furthermore, in the hepatic cytosol, the activity of SOD and catalase 
were significantly reduced (Ohara et al. 2008a). Similar results were also found in 
a study by Ohara et al. (2009), in which the activities of catalase, GPx and 
glutathione reductase were decreased in the liver of WKY rats. However, a 
significant elevation in hepatic SOD levels was found. The study also found an 
increase in blood pressure in the canola oil fed WKY rats compared to the 
soybean oil group (Ohara et al. 2009). Furthermore, the enhanced activity of 
G6PD in the liver may increase NADPH oxidase production and facilitate 
lipogenesis, and possibly oxidative stress. Alternatively, the increased activity of 
G6PD may be a protective adaptation against enhanced oxidative stress, as 
increased G6PD can provide a source of electrons for the reduction of glutathione 
reductase which converts GSSG to GSH (O'Brien et al. 2000). However, the 
expression of NADPH oxidase has not been analysed, and this may provide 
evidence into whether the generation of ROS is increased. As noted above, the 
oxidative status is altered in canola oil fed SHR and WKY rats; therefore, the role 
of oxidative stress in canola oil fed SHRSP rats requires further investigation. 
 
In addition, the unfavourable effects of canola oil ingestion seem to be confined 
and only seen in SHRSP rats and its related strains (SHR and WKY rats). This is 
evident from a study carried out by Ohara et al. (2008b), which found that canola 
oil ingestion did not induce any abnormalities in the Wistar rats, except increase 
plasma concentrations of Na
+
 and aldosterone compared to the soybean oil group. 
The results suggest that the unfavourable effects of canola oil ingestion appear to 
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be restricted to SHRSP, SHR and WKY rats. Furthermore, a study by Tatematsu 
et al. (2004) examined the effect of canola oil and soybean oil intake in SHRSP 
rats through 2 generations. The authors postulated that the factors responsible for 
the life shortening effect of canola oil may be transmissible to the next generation. 
The study found that the male pups from the canola oil fed dams had retarded 
growth. In addition, the pups from the canola oil dams and the soybean oil dams 
that were weaned on the canola oil diet till 4 weeks old had significantly reduced 
lifespan compared with the pups that were weaned with soybean oil (Tatematsu et 
al. 2004). 
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Table 2.1: Summary of the lifespan studies examining canola oil fed SHRSP rats compared to soybean oil  
Studies Experiment Diets Findings 
Mean survival time (days) 
Soybean Oil Canola Oil 
Huang et al. 
(1996) 
• Lifespan study • SHRSP rats fed: 10 wt/wt% 
canola, soybean, perilla or 
microbial oil. 
• 1% NaCl loading 
• Canola oil intake significantly reduced the lifespan 
compared to all other diets 
• No difference in systolic and diastolic blood pressure 
in all dietary groups 
79.6 50.1* 
Ratnayake et 
al. (2000a) 
• Lifespan study 
• 37 day feeding 
trial for tissue 
analysis 
• SHRSP rats fed: 10 wt/wt% 
soybean oil, canola oil, high-
palmitic canola oil, low-sulphur 
canola oil, high-oleic safflower 
oil, a fat blend mimicking fatty 
composition of canola oil, fat 
blend high in saturated fatty 
acids or normal rat chow. 
• 1% NaCl loading 
• Survival times were not different between the canola 
oil and low-sulphur canola oil group 
• Groups given the non-canola oil based diets lived 
longer than groups on canola oil and low-sulphur 
canola oil 
• No differences in fatty acid composition of RBCs and 
liver from the animals in each group  
102 ±  15.4 88 ± 10.4* 
Ratnayake et 
al. (2000b) 
• Lifespan study   
• 30-32 day 
feeding trial for 
blood and tissue 
analysis 
• SHRSP rats fed: canola oil, 
soybean oil, canola oil + 
phytosterols, soybean oil + 
phytosterols, corn oil, olive oil 
or Canadian fat mimic. 
• 1% NaCl loading 
• Lifespan of rats fed canola oil, canola oil + 
phytosterols, soybean oil + phytosterols and corn oil 
significantly shorter compared to soybean oil and 
Canadian fat mimic 
• Groups fed high phytosterol diets had greater levels 
of phytosterols in plasma, RBC, liver and kidney 
95 ± 9.3 87 ± 4* 
Ogawa et al. 
(2003) 
• Lifespan study 
• Tissue analysis 
in SHRSP rats, 
WKY and Wistar 
rats  
• SHRSP rats fed: 10 wt/wt% 
canola oil, soybean oil, 
soybean oil + 0.06% 
phytosterol or soybean oil + 
4.5% phytosterol. 
• 1% NaCl loading 
• Addition of phytosterols to soybean oil caused an 
increased in SBP and promoted the onset of stroke 
• Intestinal mRNA expression of Abcg5 and Abcg8 
were decreased in SHRSP and WKY rats compared 
with Wistar rats 
117.9 ± 7.1 99.5 ± 3.5* 
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*Statically significant P < 0.05 
Studies Experiment Diets Findings 
Mean survival time (days) 
Soybean Oil Canola Oil 
Natio et al. 
(2003) 
• Lifespan study 
• 4 week feeding 
trial for tissue 
analysis 
• SHRSP rats fed: 10 wt/wt% 
canola oil or soybean oil. 
• 1% NaCl loading 
• Mean systolic blood pressure was higher in canola oil 
compared to soybean oil group (233 ± 2 and 223 ± 3 
mmHg, respectively) 
•  phytosterol levels in plasma and RBC membranes 
in canola oil group 
•  Na+, K+-ATPase activities in brain, heart and 
kidneys in canola oil group 
68 ± 3 62 ± 2* 
Ohara et al. 
(2006) 
• Lifespan study 
• 8 week feeding 
trial for tissue 
analysis 
• SHRSP rats fed: 10 wt/wt% 
soybean oil, canola oil, 180-
bar fraction, 350-bar fraction or 
residue fraction. 
• 0.5% NaCl loading 
• Lifespan was significantly shorter in the canola oil, 
350-bar fraction and the residue fraction groups 
• In the kidney, chronic nephropathy was common in 
the canola oil and fraction groups.  
• Cerebral necrosis was found in the residue group 
63 ± 3 53 ± 2* 
Papazzo et 
al. (2011) 
• Lifespan study 
 
• SHRSP rats fed: 10 wt/wt% 
soybean oil or canola oil 
• 1% NaCl loading 
• Canola oil intake significantly reduced the lifespan 
compared to soybean oil. 
• Canola oil intake lead to changes in oxidative status 
98.3 ± 3.4 85.8 ± 1.1* 
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2.5.2 Canola oil and human health 
Canola oil is considered to provide positive cardiovascular benefits due to its 
favourable fatty acid content (Ratnayake et al. 2000a).  A study by Lichtenstein et 
al. (1993) assessed the effect of different vegetable oils which are high in 
monounsaturated or polyunsaturated fatty acids on plasma lipids as part of the 
National Cholesterol Education Program (NCEP) Step 2 diet in humans. The 
study consisted of middle-aged and elderly subjects (mean age 61 years), and 
were given diets containing canola, olive or corn oil. The results showed that the 
consumption of canola, corn and olive oil enriched diets significantly reduced 
plasma cholesterol concentrations, plasma low-density lipoprotein cholesterol 
(LDL-C) and apolipoprotein (apo)B levels. It is evident that canola oil is 
considered to provide positive effects in middle-aged and elderly 
hypercholesterolemic subjects. Saturated fatty acids in the diet can be substituted 
with oils rich in polyunsaturated or monounsaturated fatty acids as part of the 
NCEP Step 2 diet (Lichtenstein et al. 1993). In addition, a study by McDonald et 
al. (1989) evaluated the changes caused by dietary lipids to plasma lipids and 
lipoproteins and the production of thromboxane A2 and prostacyclin in vivo in 
healthy young men aged between 19 – 32 years. The young men were given 75% 
of fat added to their diet, and given either canola oil or sunflower oil for 18 days 
during the experimental period. Canola oil reduced total plasma cholesterol and 
LDL-C in the young men, and the results were similar to that of sunflower oil 
(McDonald et al. 1989). Evidence suggests that canola oil has antithrombotic 
effects as bleeding times were found to be longer and prostacyclin production 
increased (McDonald et al. 1989). A study by Sticker et al. (2008) found that in 
patients with peripheral arterial occlusive disease, 2 tablespoons/day of canola oil 
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for 8 weeks decreased total cholesterol and LDL-C levels, and improved 
endothelial function compared with sunflower oil (Sticker et al. 2008). However, 
there were a number of limitations to this study. At baseline, there was 
randomisation between the canola oil and sunflower oil groups, which included 
unmatched medications and significance in endothelial function and heart rate 
variability measures. Food diaries were not taken before the commencement of 
the trial, which would have provided information about the patient’s diet, as this 
could have influenced the results between the groups. Overall, the results 
obtained in this study may not be a true representative of what is occurring as a 
result of canola oil intake. Further research is required to investigate the effects of 
canola oil ingestion in patients with CVD. Furthermore, in 1981 toxic oil 
syndrome appeared in Spain due to the ingestion of canola oil which had been 
denaturated with aniline and marketed for human consumption. It affected more 
than 20,000 people and has caused 2500 deaths (Valades et al. 2003). Valades et 
al. (2003) carried out a cohort study with a total of 20,084 toxic oil syndrome 
subjects between the periods of 1981 to 1995. The shortest survival times were 
for women and subjects < 40 years of age. The major clinical manifestations 
observed include: liver disease, motor neuropathy, pulmonary infection, 
pulmonary hypertension and eosinophilia (Valades et al. 2003). In addition, 
experimental and epidemiological findings suggest that the use of unrefined 
canola oil in high temperature wok cooking has been associated with increased 
lung cancer in China (Shields et al. 1995). There has been no other evidence 
reported showing that canola oil ingestion has a negative impact on human health. 
It is possible that the observed effect of canola oil has been overlooked in human 
nutrition, as many people consume an abundance of saturated fatty acids from 
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different sources (Okuyama et al. 1997). If there is a subsection of the human 
population that responds in a similar manner as SHRSP rats to canola oil, then 
this could be an important clinical area that warrants investigation. 
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CHAPTER 3   
Differential effects of dietary canola and soybean oil 
intake on oxidative stress in stroke-prone 
spontaneously hypertensive rats 
 
 
Publication  
Papazzo, A., Conlan, X. A., Lexis, L. and Lewandowski, P. A. (2011). 
“Differential effects of dietary canola and soybean oil intake on oxidative stress 
in stroke-prone spontaneously hypertensive rats.” Lipids in Health and Disease. 
10:98. 
 
 
3.1 Abstract  
Background 
Canola oil shortens the lifespan of SHRSP rats compared with rats fed soybean 
oil when given as the sole dietary lipid source. One possible mechanism leading 
to the damage and deterioration of organs due to canola oil ingestion is oxidative 
stress. This study investigated the effect of canola oil intake on oxidative stress in 
this animal model.  
Method 
Male SHRSP rats, were fed a defatted control diet containing 10 wt/wt% soybean 
oil or a defatted treatment diet containing 10 wt/wt% canola oil, and given water 
containing 1% NaCl. Blood pressure was measured weekly. Blood was collected 
prior to beginning the diets and at the end of completion of the study for analysis 
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RBC antioxidant enzymes, RBC and plasma MDA, plasma 8-isoprostane and 
plasma lipids.  
Results 
Canola oil ingestion significantly decreased the lifespan of SHRSP rats compared 
with soybean oil, 85.8 ± 1.1 and 98.3 ± 3.4 days, respectively. Systolic blood 
pressure increased over time with a significant difference between the diets at the 
6
th
 week of feeding. Canola oil ingestion significantly reduced RBC SOD, GPx 
and catalase activities, total cholesterol and LDL-C compared with soybean oil. 
There were no significant differences in RBC MDA concentration between 
canola oil fed and soybean oil fed rats. In contrast, plasma MDA concentration 
and 8-isoprostane was significantly lower in the canola oil group compared to the 
soybean oil group.  
Conclusion 
In conclusion, canola oil ingestion shortens the lifespan of SHRSP rats and leads 
to changes in oxidative status, despite an improvement in the plasma lipids. 
 
 
3.2 Introduction 
The SHRSP rat is a model of human essential hypertension and stroke, and is 
derived from the SHR and the WKY rat strain (Huang et al. 1997; Ogawa et al. 
2003; Okamoto et al. 1974; Tatematsu et al. 2004). In this model, ingestion of 
canola oil as the sole dietary fat source (added at 10 wt/wt% to standard rat chow) 
has been reported to shorten lifespan compared to the soybean oil or perilla oil 
(Huang et al. 1996 & 1997; Natio et al. 2003; Ogawa et al. 2003; Ohara et al. 
2006; Ratnayake et al. 2000a & 2000b). The sulphur and fatty acid composition 
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of canola oil does not appear to cause the shortened life span (Ratnayake et al. 
2000a). Furthermore, the concentration of phytosterols in canola oil has also been 
suggested to be a contributing factor (Natio et al. 2000a & 2003, Ogawa et al. 
2003; Ratnayake et al. 2000b). However, conflicting results have shown no clear 
correlation between the content of phytosterols in the diet and tissues and survival 
time observed (Ohara et al. 2006; Tatematsu et al. 2004). Recent studies suggest 
that one of the key mechanisms leading to the shortened lifespan in SHRSP rats is 
via the acceleration of hypertension-related deterioration of organs (Natio et al. 
2003; Ohara et al. 2006). An increase in blood pressure (Natio et al. 2000c) and 
enhanced Na+, K+-ATPase activities (Natio et al. 2003) have been reported as a 
result of canola oil ingestion, and may promote the deterioration of organs. Other 
hypertension-related conditions induced by canola oil ingestion include tissue 
lesions in the heart and kidney (Ohara et al. 2006).  
 
There is growing evidence that oxidative stress leads to vascular damage and 
plays a critical role in the pathogenesis of cardiovascular diseases such as 
hypertension (Berry et al. 2001; Fearon & Faux 2009). It has been found that 
production of ROS is increased in both experimental and clinical hypertension, 
with a decrease in the antioxidant reserve in vascular tissues (de Champlain et al. 
2004; Touyz & Schiffrin 2004). In both experimental and clinical hypertension, 
ROS and oxidative stress have been found to be associated with end-stage organ 
damage (Touyz & Schiffrin 2004). Hypertension is also a risk factor for stroke 
(Lo et al. 2003). It has been shown that in both ischemic and hemorrhagic stroke, 
ROS production is increased, and oxidative stress is a key mediator of tissue 
damage (Cherubini et al. 2005; Lo et al. 2003).   
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Cells are protected against ROS by a complex antioxidant system present within 
the cells, which includes SOD, catalase and GPx (Lakomkin et al. 2005). Within 
RBCs, protective mechanisms exist to detoxify and scavenge ROS, and protect 
endothelial cells against free radical damage (Richards et al. 1998). There is an 
inverse relationship between reduced activities of antioxidants (SOD, GPx and 
vitamin E) and increased lipid peroxidation products in blood and cardiovascular 
disease (Kalenikova et al. 2004). The activities of the antioxidant enzymes, SOD, 
catalase and GPx have been found to be reduced both in whole blood and 
peripheral mononuclear cells in hypertensive subjects (Redon et al. 2003). In 
addition, concentrations of MDA in whole blood and peripheral mononuclear 
cells have been shown to be increased in hypertensive subjects compared to 
control (Redon et al. 2003). MDA is an end product of lipid peroxidation, and 
therefore increased concentrations indicate an increase in ROS concentration and 
resulting oxidative damage (Redon et al. 2003). After an acute ischemic stroke 
the activities of SOD and GPx were reduced and the concentration of MDA was 
increased in RBCs of human subjects (Demirkaya et al. 2001). This study aimed 
to determine if enhanced oxidative stress and altered antioxidant capacity is 
associated with canola oil ingestion in SHRSP rats. 
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3.3 Materials and methods 
3.3.1 Animal husbandry and study design 
Experimental design was based on previous lifespan studies investigating canola 
oil intake in SHRSP rats (Natio et al. 2003) to allow direct comparisons to be 
made. Thirty-four male SHRSP rats (Deakin University, Australia) were used for 
this study. Ten of the SHRSP rats were sacrificed at 5 weeks of age and blood 
was collected for analysis (pre-treatment data). Twenty-four 4 week old SHRSP 
rats were randomly assigned to a control and treatment group and acclimatized 
for one week. During acclimatization they were given a standard pellet diet 
(Specialty Feeds, Western Australia) and water ad libitum. Male rats were used as 
previous studies investigating the canola oil-induced life shortening effect in 
SHRSP rats were carried out using male animals. Following this, the two groups 
were fed, respectively, a defatted control diet containing 10 wt/wt% soybean oil 
or a defatted treatment diet containing 10 wt/wt% canola oil (Speciality Feeds, 
Western Australia), and life span was determined. The fatty acid compositions 
and total antioxidant status of the diets are shown in Table 3.1. Each group was 
given water containing 1% NaCl to accelerate the development of hypertension. 
This has been used in previous lifespan studies investigating canola oil intake in 
SHRSP rats (Huang et al. 1996 & 1997; Natio et al. 2003; Ogawa et al. 2003; 
Ohara et al. 2006; Ratnayake et al. 2000a & 2000b). The rats were housed in pairs 
in plastic cages with saw dust/timber shavings as the bedding. The animals were 
maintained on a 12 hr light/dark photo-period with a room temperature of 21 ± 
2°C. Animal body weights, food intake and water consumption were determined 
once a week, while the health of the animals was monitored daily. When a rat was 
found to suffer from stroke, paralysis, to be in pain or to have lost > 25% of their 
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body weight they were anaesthetised via intra-peritoneal injection with lethabarb 
(50 mg/kg), and blood was collected for analysis (post-treatment data). Approval 
for this project was granted by the Deakin University Animal Welfare Committee 
(Ethics approval no. A21/08).  
 
Table 3.1: Fatty acid composition of canola oil and soybean oil diets. 
Fatty acid  Soybean oil (%) Canola oil (%) 
14:0 Myristic acid 0.2 0.1 
16:0 Palmitic acid 11.0 7.0 
16:1 Palmitoleic acid 0.1 0.1 
18:0 Stearic acid 4.0 2.0 
18:1 Oleic acid 23.0 53.0 
18:2 Linoleic acid 48.0 23.0 
18:3 Linolenic acid 6.0 10.0 
18:4 Stearidonic acid 0 0.5 
20:1 Gadoleic acid 0.2 0.1 
20:5 EPA 0.2* 0.2* 
22:6 DHA 0.5* 0.5* 
Total Antioxidant Status 
(TEAC mmol/L) 
0.67 ± 0.01 0.66 ± 0.01 
*Fatty acid source coming from fish meal found within the diet.  
Information provided by Speciality Feeds (Western Australia), which 
produced both diets.   
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3.3.2 Measurement of blood pressure 
Blood pressure was measured weekly in all the treatment groups using a tail cuff 
sphygmomanometer (Biopac Systems, USA). The animals were placed into a 
restraint and the tail was warmed briefly under a heat lamp. Then the latex cuff 
was placed around the base of the tail and the blood pressure was recorded. For 
each animal systolic blood pressure was obtained as an average of three readings. 
 
3.3.3 Blood collection and processing 
After the animal was anaesthetised, blood was collected via cardiac puncture into 
EDTA coated tubes. Immediately after blood collection, samples were 
centrifuged at 600 xg for 10 minutes at 4°C. The plasma was then removed and 
stored at -80°C until analysis of plasma lipids: triglycerides, total cholesterol, 
high density lipoprotein cholesterol (HDL-C) and LDL-C, and MDA. RBCs were 
then washed 3 times by adding an equal volume of 0.9% (w/v) NaCl, mixed 
carefully and centrifuged at 4ºC at 600 xg for 10 minutes. The supernatant was 
removed and discarded. An equal volume of cold distilled water and RBCs were 
mixed well to lyse the cells. The hemolysate was stored at - 80ºC for subsequent 
analysis of antioxidant enzymes: SOD, catalase and GPx, and MDA. 
 
3.3.4 Erythrocyte antioxidant enzymes 
3.3.4.1SOD assay 
SOD activity was determined using a commercially available kit (Cayman 
Chemical Company, USA) following manufactures instructions. This assay 
utilizes xanthine oxidase and hypoxanthine to generate superoxide radicals 
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detected by tetrazolium salt. One unit of SOD is defined as the amount of enzyme 
required to inhibit the distmutation of the superoxide radical by 50%.  
 
Firstly, all reagents within the kit were equilibrated to room temperature prior to 
beginning the assay. Then the following reagents were prepared. The assay buffer 
dilute was made up by adding 3 ml assay buffer concentrate provided to 27 ml 
milli-Q water. The sample buffer was made up by adding 2 ml sample buffer 
concentrate provided to 18 ml milli-Q water. The radical detector was made up 
prior to use, and 50 µl of radical detector was added to 19.95 ml assay buffer 
dilute. Xanthine oxidase was made up by adding 50 µl of the enzyme to 1.95 ml 
sample buffer dilute and stored on ice. The SOD stock standard (4.25 mM) was 
prepared by diluting 20 µl of SOD standard with 1.98 ml sample buffer dilute. 
Then the SOD stock was further diluted in separate eppendorf tubes with sample 
buffer dilute as shown in Table 3.2. 
 
Table 3.2: SOD standards 
Tube Formaldehyde 
Stock (µl) 
Sample Buffer 
(µl) 
Final Concentration 
(µM formaldehyde) 
A 0 1,000 0 
B 10 980 5 
C 40 960 15 
D 80 920 30 
E 120 880 45 
F 160 840 60 
G 200 800 75 
 
 
The SOD reaction was set up in a 96 well plate. Firstly, 200 µl of diluted radical 
detector and 10 µl of standard were added to the designated wells on the plate. 
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Then, the positive control wells were prepared: 200 µl of diluted radical detector 
and 10 µl of diluted catalase were added to two wells. Next the sample wells were 
prepared: 200 µl of diluted radical detector and 10 µl of sample to two wells. 
Then the reaction was initiated by adding 20 µl of dilute xanthine oxidase to all 
the wells. The plate was covered and incubated at room temperature for 20 
minutes. Next, the absorbance was read at 540 nm using a microplate analyser 
(Fusion-Alpha HT, PerkinElmer).   
 
3.3.4.2 Catalase assay 
Catalase activity was determined using a commercially available kit (Cayman 
Chemical Company, USA) following manufactures instructions. This method is 
based on the reaction of methanol with the enzyme in the presence of an optimal 
concentration of hydrogen peroxide.  
 
Firstly, all the reagents within the kit were equilibrated to room temperature prior 
to beginning the assay. Then the following reagents were prepared. The assay 
buffer was made up by adding 2 ml assay buffer to 18 ml milli-Q water. The 
samples buffer was made up by adding 5 ml sample buffer to 45 ml milli-Q 
water. The catalase control was made up by reconstituting the catalase enzyme 
with 2 ml sample buffer dilute. Then 100 µl of the reconstituted enzyme was 
added to 1.9 ml sample buffer dilute, store on ice. Potassium hydroxide was made 
up by adding 4 ml cold milli-Q water. Hydrogen peroxide was made up by adding 
40 µl hydrogen peroxide with 9.96 ml milli-Q water. The hemolysate was diluted 
to 3000/1 using sample buffer dilute. The formaldehyde stock standard (4.25 
mM) was prepared by diluting 10 µl of formaldehyde standard with 9.99 ml 
48 
 
sample buffer. Then the formaldehyde stock was further diluted in separate 
eppendorf tubes (labelled A-G) with sample buffer as shown in Table 3.3. 
 
Table 3.3: Formaldehyde standards 
Tube Formaldehyde 
Stock (µl) 
Sample Buffer 
(µl) 
Final Concentration 
(µM formaldehyde) 
A 0 1,000 0 
B 10 990 5 
C 30 970 15 
D 60 940 30 
E 90 910 45 
F 120 880 60 
G 150 850 75 
 
 
 
The catalase reaction was set up in a 96 well plate. Firstly, 100 µl of assay buffer, 
30 µl of methanol and 20 µl of standard was added to the designated wells on the 
plate. Then, the positive control wells were prepared: 100 µl of assay buffer, 30 
µl methanol and 20 µl of diluted catalase were added to two wells. Next the 
sample wells were prepared: 100 µl of assay buffer, 30 µl methanol and 20 µl of 
sample to two wells. Then the reaction was initiated by adding 20 µl of dilute 
hydrogen peroxide to all the wells. The plate was covered and incubated at room 
temperature for 20 minutes. Then to each well 30 µl of potassium hydroxide was 
added followed by 30 µl of Purpald (chromogen). The plate was covered, placed 
on a platform shaker and incubated at room temperature for 10 minutes. Then, to 
each well 10 µl of potassium periodate was added and the plate was covered and 
further incubated at room temperature for five minutes on a platform shaker. 
Next, the plate was placed in a microplate analyser (Fusion-Alpha HT, 
PerkinElmer) and the absorbance read at 540 nm.  
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3.3.4.3 GPx assay 
GPx activity was determined using a modification of the method of Wheeler et al. 
1990. This assay is based on the oxidation of NADPH following the reduction of 
t-butyl hydroperoxide. A decrease in absorbance at 340 nm results from oxidation 
of NADPH to NADP+ and the rate of this decrease is proportional to the GPx 
activity in the sample.  
 
Firstly the NADPH, glutathione reductase, glutathione, daily reagent and start 
reagent solutions were prepared. The NADPH solution was made up by mixing 4 
mg of NADPH together with 2.133 ml of 0.1% NaHCO3. The glutathione 
reductase solution was made up by adding 13 µl glutathione reductase to 250 µl 
phosphate buffer, pH 7.0. The glutathione solution was made up by mixing 35 mg 
of glutathione reductase together with 500 µl phosphate buffer, pH 7.0. The daily 
reagent was made up by adding 9.25 ml of phosphate buffer, pH 7.0, 1.25 ml 
NADPH solution, 0.250 µl glutathione reductase solution and 500 µl glutathione 
solution. The start reagent was made by adding 10 ml of distilled water along 
with 18.5 µl of t-butyl hydroperoxide. The hemolysate was diluted to 300/1 with 
distilled water. Next, 24 µl of sample, 30 µl of distilled water and 135 µl of daily 
reagent was added to a cuvette and incubated at room temperature for 50 seconds. 
Then to the cuvette 20 µl of start reagent and 16 µl distilled water was added and 
the absorbance read every 25 seconds for 4 minutes and 10 seconds at 340 nm 
using a spectrophotometer (Biochrom, USA). 
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3.3.5 Haemoglobin assay 
The antioxidant enzymes were all normalised to haemoglobin. Firstly, the 
hemolysate was diluted to 1:20 by adding 6 µl hemolysate to 54 µl distilled water. 
Then to a cuvette, 20 µl of diluted hemolysate was added to 480 µl Darbkin’s 
solution (1:500 dilution), mixed and left to stand for 5 minutes. Then the 
absorbance was read at 540 nm using a spectrophotometer (Biochrom, USA). The 
haemoglobin concentration for each sample was calculated using the following 
equation:  
Hb (g/ml) = Abs/44 x 64.458 x 401/10 
Where:  
Abs = absorbance @ 540 nm of 500/1 dilution of sample in Drabkins 
64.458 = molecular weight of Hb (g/mol) 
44 = millimolar extinction coefficient of Hb at 540 nm 
 
The GPx samples were normalised to haemoglobin using the following equations:  
Equation 1: Hb sample = Hb (g/ml)/100 x 24/300 
Equation 2: GPx U/ml Hb = GPx sample (U)/equation 1 
Where:  
100 = conversion of g/dL to g/ml 
24 = GPx sample quantity 
300 = GPx sample dilution   
 
The SOD samples were normalised to haemoglobin using the following equation: 
SOD U/gm Hb = SOD sample (U/ml)/Hb (g/ml) 
 
The catalase samples were normalised to haemoglobin using the following 
equation: 
Catalase mmol/min/gm Hb = Catalase sample (nmol/min/ml)/Hb 
(g/ml)/1000 
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3.3.6 Lipid peroxidation analysis 
3.3.6.1 MDA    
MDA was determined via high performance liquid chromatography (HPLC) in 
plasma and erythrocytes according to the method by Sim et al. 2003. The 
principle of this method is that 2,4-di-nitrophenylhydrazine (DNPH) is used to 
derivatise MDA contained in plasma or erythrocytes which forms stable 
hydrazones that can be easily separated by HPLC.  
 
The MDA standard stock solution (10 mM) was prepared by adding 23.9 µl of 
tetraethoxypropane to 10 ml 1% sulphuric acid. This stock solution was further 
diluted to100 µM by adding 50 µl standard stock solution to 4.95 ml milli-Q 
water. External standards of MDA aliquots of suitable concentrations were used 
by diluting the 100 µM standard solution as shown in table 3.4. Standards were 
prepared for the analysis of plasma and hemolysate samples. For the analysis of 
the plasma samples, 50 µl of each standard along with 50 µl distilled water was 
added to separate eppendorf tubes. For the analysis of the hemolysate samples, 
100 µl of each standard was added to separate eppendorf tubes. Then the 
standards were treated in the same manner as the samples, described below.  
 
Table 3.4: MDA standards 
Final µM 
concentration of 
standard 
Volume (µl) of 100 
µm standard 
Volume of milli-Q 
water (µl) 
5 50 950 
10 100 900 
20 200 800 
40 400 600 
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The hemolysate samples were diluted to 1 in 4 using distilled water. Then, 100 µl 
of the hemolysate samples or 50 µl of the plasma samples along with 50 µl of 
distilled water were added to separate eppendorf tubes. To the standards and 
samples 400 µl of 1.3 M sodium hydroxide (NaOH) was added to hydrolyse the 
standards and samples, then the eppendorf tubes were vortexed, incubated at  
60°C for 60 minutes and cooled on ice for 5 minutes. To precipitate the proteins, 
200 µl of 35% perchloric acid was added to the samples and standards, cooled on 
ice for 5 minutes and centrifuged at 8000 rpm for 10 minutes. Then, 650 µl of the 
supernant was removed and placed into an eppendorf tube. The standards and 
samples were protected from light from this step onwards. To the supernant, 30 µl 
of DNPH reagent was added and incubated for 10 minutes at room temperature. 
Next, the aqueous phase was extracted by adding 700 µl of hexane, and the 
eppendorfs were placed on a platform shaker for 10 minutes at room temperature. 
Then, 650 µl of the aqueous phase (hexane layer, supernant) was removed and 
transferred into eppendorf tubes.  The extraction of the aqueous phase was 
repeated a further time, and to the pellet 700 µl of hexane was added, and the 
eppendorfs were placed on a platform shaker for 10 minutes at room temperature. 
The aqueous phase was removed and transferred and combined with the first 
extracted aqueous phase. The hexane was evaporated and the dry extract was 
reconstituted with a 100 µl mobile phase, which contains 450 ml acetonitrile, 550 
ml distilled water and 2 ml glacial acetic acid (the mobile phase was filtered and 
degassed prior to use). Then, a volume of 45 µl was injected into the column for 
analysis. MDA concentrations were determined at 310 nm using HPLC (Agilent 
Technologies, Australia) with an Eclipse XDB-C18 column (150 x 4.6 mm, 5 
µm, 1 ml/min flow rate, 9.8 MPa backpressure). 
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3.3.6.1 8-isoprostane  
Total 8-isoprostane concentrations were analysed in plasma using an enzyme 
immunoassay (EIA) kit (Cayman Chemicals, USA) following manufactures 
instructions. This assay is based on the competition between 8-isoprostane and an 
8-isoprostane acetycholinesterase (AChE) conjugate for a limited number of 8-
isoprostane -specific rabbit anti-serum binding sites.   
 
The plasma samples were prepared by using the method from Cell Biolabs, INC. 
The plasma samples were hydrolysed by adding 25 µl 2M NaOH to 100 µl 
plasma sample. The samples were incubated at 45°C for 2 hours. Following this, 
25 µl 10N HCl acid was added and the samples were centrifuged for 5 minutes at 
12,000 RPM. The supernatant was removed and used for the determination of 
total 8-isoprostane using the EIA kit.  
 
The standards were prepared by transferring 100 µl 8-isoprostane EIA standard 
into an eppendorf tube along with 900 µl milli-Q water (standard stock 
concentration  5 ng/ml).  Then 8 eppendorf tubes were labelled from 1 to 8, and 
900 µl EIA buffer was added to the eppendorf tube labelled 1 and 750 µl EIA 
buffer to the eppendorf tubes labelled 2-8. Then 100 µl of standard stock (5 
ng/ml) was transferred to tube 1 and mixed thoroughly. The standards were 
serially diluted by removing 500 µl from tube 1 and placing in tube 2; mixed 
thoroughly. Next, 500 µl from tube 2 was removed and placed in tube 3; mixed 
thoroughly. This process was repeated for tubes 4-8.  
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The reactions were set up in a mouse anti-rabbit IgG coated plate. To the non-
specific binding (NSB) wells and to the maximum binding (B0) wells 10 µl EIA 
buffer or 50 µl EIA buffer were added, respectively. Next, 50 µl of standard or 
sample were added to the wells. Following this 50 µl 8-isoprostane AChE tracer 
was added to the well except to the total activity (TA) and blank (Blk) wells. 
Then, 50 µl 8-isoprostane EIA antiserum was added to to each well except to the 
TA, NSA and Blk wells. The plate was incubated at 4°C for 18 hours. The wells 
were emptied and rinsed 5 times with wash buffer. Next, 200 µl Ellman’s reagent 
was added to each well and to the TA wells 5 µl of tracer was added. The plate 
was covered with foil and incubated at room temperature for 90 minutes. The 
plate cover was removed and the absorbance read between 405-420 nm using a 
microplate analyser (Fusion-Alpha HT, PerkinElmer).  
 
3.3.7 Plasma lipids analysis 
3.3.7.1 Triglycerides 
Plasma triglycerides were determined using a commercially available kit (Thermo 
Scientific, USA). This procedure was set up in a 96 well plate, and 3 µl of 
calibrator or sample was added to 300 µl of triglyceride reagent and incubated at 
37°C for 5 minutes. The absorbance was read at 500 nm using a microplate 
analyser (Fusion-Alpha HT, PerkinElmer). 
 
3.3.7.2 Total cholesterol 
Total cholesterol was determined using a commercially available kit (Thermo 
Scientific, USA). This procedure was set up in a 96 well plate, and 3 µl of 
calibrator or sample was added to 300 µl of cholesterol reagent and incubated at 
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37°C for 5 minutes. The absorbance was read at 500 nm using a microplate 
analyser (Fusion-Alpha HT, PerkinElmer). 
 
3.3.7.3 HDL-C 
HDL-C was determined using a commercially available kit (Thermo Scientific, 
USA). This procedure was set up in a 96 well plate, and 4 µl of calibrator or 
sample was added to 300 µl of HDL reagent 1 and incubated at 37°C for 5 
minutes. Then, 100 µl of HDL reagent 2 was added and incubated at 37°C for 3 
minutes. The absorbance was read at 600 nm using a microplate analyser (Fusion-
Alpha HT, PerkinElmer). 
 
3.3.7.4 LDL-C  
LDL-C was determined using the Friedewald equation (Warnick et al. 1990): 
LDL cholesterol = Total Cholesterol – HDL cholesterol – (TG/5).   
 
3.3.8 Statistical analysis  
Statistical analysis was performed using the SPSS statistical package (version 
17.0, SPSS Inc.) for repeated measures ANOVA and one-way ANOVA. The 
results are represented as mean ± SEM. Comparisons between groups for animal 
body weight, food intake and water intake data were analysed using repeated 
measures ANOVA. A post hoc pair-wise comparison was also carried out. 
Statistical analysis of the survival time data was performed by Log-Rank and 
Wilcoxon’s nonparametric tests using GraphPad Prism 5 software. The 
differences between group means for the antioxidant enzymes, MDA and plasma 
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lipids were made by one-way ANOVA. Significance was established at the 95% 
confidence level (P < 0.05).  
 
 
3.4 Results 
3.4.1 Establishment of canola-induced life shortening model 
Canola oil ingestion significantly decreased the lifespan of SHRSP rats (P < 
0.001). Mean lifespan of the two diets was 98.27 ± 3.35 days in the soybean oil 
group compared to 85.83 ± 1.13 days in the canola oil group (Figure 3.1), 
confirming the establishment of the model.  
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Figure 3.1: Survival curves of SHRSP rats fed a diet containing 10% 
soybean oil or canola oil with 1% NaCl loading.  
The curves are significantly different (P < 0.001, Log-rank and Wilcoxon’s 
test). At the commencement of the study the number of animals in each 
group was 12.  
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3.4.2 Body weight, food intake and water intake 
Body weight of the animals increased gradually until the 5
th
 week of 
administration in both diet groups (Figure 3.2). There were no significant 
differences (P > 0.05) between soybean oil and canola oil groups. There were 
also no significant differences (P > 0.05) in food consumption and water intake 
between the soybean oil and canola oil groups (Figure 3.3).  
 
 
Figure 3.2: Mean body weight of SHRSP rats fed canola oil compared 
with soybean oil diet.  
Vaules are means ± SEM. At the commencement of the study the number 
of animals in each group was 12. The numbers on the graph repesent the 
n in each group.    
*P < 0.05 represents a significant difference between canola and soybean 
oil groups.  
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Figure 3.3: Food and water intake of SHRSP rats fed canola oil 
compared with soybean oil diet.  
Values are means ± SEM. At the commencement of the study the number 
of animals in each group was 12. The numbers on the graph repesent the 
n in each group.    
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3.4.3 Blood pressure 
Mean systolic blood pressure increased over time in the soybean oil and canola 
oil groups. At the 6
th
 week of administration the mean systolic blood pressure was 
significantly higher in the canola oil group compared to soybean oil, 230.7 ± 3.52 
and 213.61 ± 3.33 mmHg, respectively (P < 0.05) (Figure 3.4).   
 
 
 
 
Figure 3.4: Mean systolic blood pressure of SHRSP rats fed canola 
oil compared with soybean oil diet.  
Vaules are means ± SEM. At the commencement of the study the number 
of animals in each group was 12.  
*P < 0.05 represents a significant difference between canola and soybean 
oil groups.   
 
* 
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3.4.4 Antioxidant enzymes and oxidative damage 
Markers of antioxidant status and oxidative damage are represented in Table 3.5. 
Canola oil ingestion significantly reduced (P < 0.05) the activities of RBC SOD, 
GPx and catalase compared to soybean oil. The activities of RBC SOD and GPx 
were significantly lower (P < 0.05) in the canola oil group compared to pre-
treatment, however, there were no significant differences (P > 0.05) between the 
soybean oil group and pre-treatment group.   
 
Canola oil ingestion significantly decreased (P < 0.05) plasma MDA and 8-
isoprostane in SHRSP rats compared to the soybean oil group. Nevertheless, 
plasma 8-isoprostane in the soybean oil group and MDA in both canola oil and 
soybean oil groups was significantly higher (P < 0.05) than the pre-treatment 
group. Lastly, RBC MDA in the soybean oil group was significantly lower (P < 
0.05) than the pre-treatment group. 
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Table 3.5: Antioxidant status and oxidative damage in SHRSP rats 
fed canola oil compared with soybean oil diet.  
 
Pre-treatment 
Post-treatment 
Soybean oil Canola oil  
RBC SOD (U/gm 
Hb) 
1608.7 ± 121.8 1454 ± 111.3 1087.2 ± 
92.9*, # 
RBC GPx (U/gm 
Hb) 
523.0 ± 25.9 512 ± 36.6 415 ± 19.4*
, #
 
RBC Catalase 
(mmol/min/gm Hb) 
155.6 ± 13.4 208.2 ± 35.1 142.4 ± 15.9* 
RBC MDA (µM) 28.6 ± 1.6 16.6 ± 3.5# 21.8 ± 3.9 
Plasma MDA (µM) 11.8 ± 0.5 17.9 ± 0.5
#
 14.9 ± 1.3*
, #
 
Plasma 8-
isoprostane (pg/ml) 
 75.2 ± 12.3 96.2 ± 3.4# 87.7 ± 3.9* 
Values are means ± SEM; Number of animals at pre-treatment was 10. 
Number of animals in each group at post-treatment for soybean oil and 
canola oil was 9 and 8, respectively. SOD, superoxide dismutase; GPx, 
glutathione peroxidase; MDA, malondialdehyde.  
*P < 0.05 represents a significant difference between canola and soybean 
oil groups; #P < 0.05 represents a significant difference between pre-
treatment vs post-treatment.  
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3.4.5 Plasma lipids 
Canola oil ingestion significantly reduced (P < 0.05) the concentration of total 
cholesterol and LDL-C compared with soybean oil. Total cholesterol and LDL-C 
were significantly lower (P < 0.05) in the canola oil group compared with pre-
treatment, however, there were no significant differences (P > 0.05) between the 
soybean oil group and pre-treatment group. HDL-C in both canola oil and 
soybean oil groups was significantly lower (P < 0.05) than the pre-treatment 
group. There were no significant differences (P > 0.05) in the concentration of 
triglycerides between groups (Table 3.6).   
 
 
Table 3.6: Plasma lipids in SHRSP rats fed canola oil compared with 
soybean oil diet. 
 Pre-treatment  
(mmol/L) 
Post-treatment (mmol/L) 
Soybean oil Canola oil 
Total cholesterol 7.9 ± 0.2 7.9 ± 0.4 6.67 ± 0.3*, # 
 LDL-C 5.3 ± 0.2 5.6 ± 0.4 4.57 ± 0.2*, # 
HDL-C 2.4 ± 0.1 1.8 ± 0.1
#
 1.67 ± 0.1
#
 
Triglycerides 1.4 ± 0.1 1.4 ± 0.1 1.21 ± 0.1 
Values are means ± SEM; Number of animals at pre-treatment was 10. 
Number of animals in each group at post-treatment for soybean oil and 
canola oil was 9 and 8, respectively.  
*P < 0.05 represents a significant difference between canola and soybean 
oil groups; #P < 0.05 represents a significant difference between pre-
treatment vs post-treatment. 
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3.5 Discussion 
Previous studies have shown that the lifespan of SHRSP rats is shortened when 
canola oil is the only dietary fat source (Huang et al. 1996 & 1997; Natio et al. 
2003; Ogawa et al. 2003; Ohara et al. 2006; Ratnayake et al. 2000a & 2000b), 
which is confirmed by the present study, which showed shortened lifespan of 
about 13% with canola oil feeding compared with soybean oil under 1% NaCl 
loading.  Our results are similar to the study published by Ratnayake et al. 
(2000b), which produced a 13% reduction in life span with canola oil feeding.  
Canola oil has been reported to shorten the life span of SHRSP rats compared 
with soybean oil, 254 ± 12 and 416 ± 16 days, respectively, even without NaCl 
loading (Huang et al. 1997).  
 
Evidence indicates that canola oil intake has an effect on blood pressure in the 
SHRSP rat and its related strains. However, blood pressure in the present study is 
not a key contributing factor to the shortened life span, as there was only one time 
difference between soybean oil and canola oil. The results of the present study 
show an increase in systolic blood pressure over time in both treatment groups, 
with a difference between the groups at the 6
th
 week of administration. A study by 
Huang et al. (1996) observed no significant change in systolic blood pressure in 
the canola oil group compared to the soybean oil group at 4 and 8 weeks of age 
(Huang et al. 1996). Another study by Ratnayake et al. (2000a) found no 
significant differences in the SBP among different dietary groups in SHRSP rats 
(Ratnayake et al. 2000a). 
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While previous literature has shown that decreased antioxidants and oxidative 
stress play a role in hypertension, to our knowledge this is the first study to 
investigate the effect of canola oil on measures of antioxidant status and oxidative 
damage in SHRSP rats. In the present study canola oil ingestion decreased the 
activities of SOD, GPx and catalase compared with the soybean oil group by 25, 
18 and 31%, respectively. Previous studies have analysed several antioxidant 
enzymes in SHR and WKY rats. In the SHR, the activity of RBC GPx and the 
activities of SOD and catalase in the hepatic cytosol were found to be reduced 
(Ohara et al. 2008). In WKY rats, canola oil ingestion reduced the activity of 
catalase in the hepatic cytosol (Ohara et al. 2009), while an earlier study showed 
reduced activities of SOD and catalase in the hepatic cytosol of WKY rats (Natio 
et al. 2000d). Our data are largely consistent with these findings. Taken together 
these results indicate that canola oil ingestion affects antioxidant enzyme activity 
in different tissues. Indeed, previous research has shown an inverse relationship 
between erythrocyte GPx activity and the incidence of cardiovascular disease 
(Blankenberg et al 2003). Given the physiological significance of the decreased 
erythrocyte GPx activity, further research is required to determine the mechanism 
to explain the canola-oil induced changes to antioxidant enzyme activity.  
 
In the present study, canola oil ingestion decreased the plasma 8-isoprostane and 
MDA concentration when compared to the soybean oil group. These results are 
unexpected given the canola oil-induced decrease in erythrocyte antioxidant 
enzyme activity. The mechanism to explain the decreased plasma 8-isoprostane 
and MDA concentration despite a decrease in RBC antioxidant enzyme activity is 
currently unknown.  Plasma 8-isoprostane in the soybean oil and MDA in both 
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the canola oil and soybean oil groups was higher than the pre-treatment group. In 
a previous study in WKY rats, canola oil ingestion increased lipid peroxide levels 
in the hepatic cytosol (Ohara et al. 2009), while an earlier study showed no 
change in lipid peroxide levels in the hepatic cytosol of SHR (Ohara et al. 2008). 
The increased plasma 8-isoprostane in the soybean oil group and MDA 
concentrations in both dietary groups compared to pre-treatment indicates an 
increased amount of ROS induced lipid peroxidation over time independent from 
the consumption of either canola or soybean oil. Previous investigations that have 
determined the potential for cellular membranes to undergo oxidation based on 
their fatty acid composition (Tsalouhidou et al. 2006) suggest that the change in 
lipid peroxidation observed in the present study is in contrast to what may be 
expected based on the fatty acid composition of canola and soybean oil. Canola 
oil has relatively more n-9 monousnsatruated fatty acids, more readily oxidised, 
compared to soybean oil that has proportionally more n-6 polyunsaturated fatty 
acids, less readily oxidised (Tatematsu et al. 2004). However, only focusing on 
the fatty acid composition alone of the two oils is too simplistic as the TAS for 
both diets was the same and the lower concentration of RBC MDA in the soybean 
oil group may have resulted from the higher RBC antioxidant activities compared 
to the canola oil group. Whichever the case the specific mechanism for these 
differences in RBC lipid peroxidation associated with the consumption of canola 
or soybean oil was not identified in the present study. Therefore, more research is 
clearly required to investigate the effect of canola oil intake on oxidative damage 
in SHRSP rats.   
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Canola oil ingestion reduced the concentration of total cholesterol and LDL-C 
compared with soybean oil and the pre-treatment group. HDL-C was lower in 
both dietary groups compared with pre-treatment, and there were no changes 
found in the triglyceride levels between the groups. However, previous studies in 
SHR and WKY rats have shown increases in total cholesterol, triglycerides and 
HDL-C with administration of canola oil compared to soybean oil (Natio et al. 
2000b & 2000d; Ohara et al. 2008 & 2009). A study by Ohara et al. (2006) found 
no changes in the plasma lipids in the canola oil group after an eight week 
feeding trial in SHRSP rats (Ohara et al. 2006). Canola oil is considered to 
provide protective cardiovascular effects due to its favourable fatty acid 
composition (Ratnayake et al. 2000b). Canola oil has a high content of oleic acid 
(55-60%), a low content of SFA (6-7%), and provides a good source of omega-3 
fats (Tatematsu et al. 2004). The present study supports the beneficial health 
effects of canola oil, as the plasma lipids were reduced in SHRSP rats. A previous 
study has shown that a canola oil rich diet reduced plasma cholesterol, LDL-C 
and HDL-C concentrations in middle-aged and elderly hypercholesterolemic 
subjects (Lichtenstein et al. 1993). Canola oil has also been shown to reduce total 
plasma cholesterol and LDL-C in the young men (McDonald et al. 1989). Whilst 
this present study supports the beneficial health effects of canola oil on blood 
lipids, it should also be pointed out that the metabolism of cholesterol in rats is 
different from cholesterol metabolism in humans (Dietschy & Wilson 1970). 
Therefore direct extrapolation of our circulating cholesterol results into humans 
must be done so with caution. However, the effects of canola oil ingestion in the 
SHRSP rat is still detrimental as this oil leads to a shorten lifespan in SHRSP rats.  
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There are a number of limitations associated with the present study in addition to 
the differences between cholesterol metabolism in rats and humans. The first is 
the question of whether the life shortening effect associated with canola oil 
consumption is specific to rats originally derived from the normotensive WKY rat 
strain. When canola oil was the only dietary fat fed to WKY rats, a significant 
increase in systolic blood pressure after five weeks of canola oil feeding was 
observed and persisted until the conclusion of the trial at week 13, compared to 
soybean oil fed rats (Natio et al. 2000).  In addition when SHR rats were fed 
canola oil canola they developed vascular lesions in the kidney, had elevated 
plasma lipids and G6PD activation in the liver and erythrocytes compared to SHR 
fed soy oil (Ohara et al. 2008a). In human populations there is only one published 
incidence of canola oil being associated with the development of disease (Posada 
de la Paz et al. 2001) and this due was to manufacturing error when producing 
canola oil. The present study did not directly investigate the effect of canola oil 
on cell membrane fatty acid composition, fluidity, antioxidant capacity or 
oxidized membrane lipids. Although MDA was measured in plasma and lysed red 
blood cells, the membrane fraction of red blood cells or other organs was not 
isolated prior to measurement of MDA. A change to cell membrane composition 
has previously been investigated as a potential mechanism to explain the life 
shortening effects of canola oil in the SHRSP rat. These previous studies 
suggested that hyperabsorption and accumulation of plant sterols found in canola 
oil altered the fluidity of the membranes present in red blood cells, liver and 
kidney and contribute to the life shortening effect observed in SHRSP rats 
(Ratnayake et al. 2000b). Finally NaCl loading is used to accelerate the 
development of hypertension in the SHRSP rat (Huang et al. 1996 & 1997; Natio 
68 
 
et al. 2003; Ogawa et al. 2003; Ohara et al. 2006; Ratnayake et al. 2000a), 
however it may be masking the effects of canola oil in the SHRSP rat, thus 
further investigation on the life shortening effect of canola oil in the absence of 
NaCl are required. 
 
In conclusion, we have shown that canola oil ingestion mediated lifespan 
shortening of SHRSP rats leads to changes in oxidative status. The plasma lipids 
were reduced after canola oil ingestion highlighting the health benefits of canola 
oil intake. Despite the improvement in the plasma lipids, canola oil is detrimental 
to the SHRSP rat as their lifespan is reduced. Further research is required to 
determine whether oxidative stress plays a role in SHRSP rats due to canola oil 
ingestion.    
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CHAPTER 4   
The effect of short-term canola oil ingestion on 
oxidative stress in the vasculature of stroke-prone 
spontaneously hypertensive rats 
 
 
Publication 
Papazzo, A., Conlan, X. A., Lexis, L. and Lewandowski, P. A. (2011). “The 
effect of short-term canola oil ingestion on oxidative stress in the vasculature of 
stroke-prone spontaneously hypertensive rats.” Lipids in Health and Disease (In 
review). 
 
 
4.1 Abstract  
Background 
This study aimed to determine if 25 days of canola oil intake in the absence of 
excess dietary salt or together with salt loading affects the antioxidant and 
oxidative stress markers in the circulation. A further aim was to determine the 
mRNA expression of NADPH oxidase subunits and SOD isoforms in the aorta of 
SHRSP rats.  
Methods 
Male SHRSP rats, were fed a defatted control diet containing 10 wt/wt% soybean 
oil or a defatted treatment diet containing 10 wt/wt% canola oil, and given tap 
water or water containing 1% NaCl. Blood was collected at the end of study for 
analysis of RBC antioxidant enzymes, RBC and plasma MDA, plasma 8-
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isoprostane and plasma lipids. The aorta was removed and the mRNA expression 
of NOX2, p22
phox
, CuZn-SOD, Mn-SOD and EC-SOD were determined.  
Results 
In the absence of salt canola oil reduced RBC SOD and GPx, and increased total 
cholesterol and LDL-C compared with soybean oil. RBC GPx was significantly 
lower in both the salt loaded groups compared to the soybean oil only group. In 
addition, RBC MDA and plasma HDL-C were significantly higher in both the salt 
loaded groups compared to the non salt groups. Plasma MDA concentration was 
higher and LDL-C concentration lower in the canola oil group loaded with salt 
compared to the canola oil group without salt. The mRNA expression of NADPH 
oxidase subunits and SOD isoforms were significantly reduced in the canola oil 
group with salt compared to canola oil group without salt.  
Conclusion  
In conclusion, these results indicate that canola oil reduces antioxidant status and 
increases plasma lipids, which are risk factors for CVD. However, canola oil in 
combination with salt intake increases MDA, a marker of lipid peroxidation and 
decreases NAPDH oxidase subunits and SOD aortic expression.  
 
 
4.2 Introduction 
Evidence has shown that ingestion of canola oil as the sole dietary fat source 
(added at 10 wt/wt% to standard rat chow) shortens the life span of SHRSP rats 
compared to the soybean oil or perilla oil (Huang et al. 1996 & 1997; Natio et al. 
2003; Ogawa et al. 2003; Ohara et al. 2006; Ratnayake et al. 2000a & 2000b). 
Our recent study strengthened this finding, and showed that canola oil ingestion 
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reduced the lifespan of SHRSP rats compared to soybean oil following 1% NaCl 
loading, 85.8 ± 1.1 and 98.3 ± 3.4 days, respectively (Papazzo et al. 2011).    
 
The mechanism by which canola oil reduces lifespan is currently unknown; 
however, decreased antioxidant activity and heightened oxidative stress have 
been implicated. The results from our lifespan study showed that canola oil intake 
reduced the antioxidant activities of RBC SOD, GPx and catalase compared to 
soybean oil in SHRSP rats following NaCl loading at the end of their lifespan 
(Papazzo et al. 2011). Furthermore, canola oil intake increased plasma MDA 
compared to pre-treatment, suggesting an increase in lipid peroxidation overtime 
(Papazzo et al. 2011). RBCs can provide protective mechanisms against oxidative 
damage to endothelial cells by neutralising ROS in the circulation (Richards et al. 
1998b). Previous research has shown an inverse relationship between reduced 
activities of antioxidants (SOD and GPx) and increased lipid peroxidation 
products in blood and cardiovascular disease (Kalenikova et al. 2004). Evidence 
has shown that in canola oil fed SHR there was an increase in RBC glutathione 
and glutathione reductase, with a decrease in the activity of RBC GPx. 
Furthermore, in the hepatic cytosol, the activity of SOD and catalase were 
significantly reduced (Ohara et al. 2008a). Similar results were also found in a 
study by Ohara et al. (2009), in which the activities of catalase, GPx and 
glutathione reductase were decreased in the liver of canola oil fed WKY rats. 
Taken together these results indicate that canola oil ingestion affects antioxidant 
enzyme activity in different tissues.  
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In vascular cells, NADPH oxidase is a major source of ROS, and is functionally 
active within all the layers of the vessel wall: in the endothelium, the media and 
the adventitia (Dworakowski et al 2008; Touyz & Schiffrin 2004; Wassmann et 
al. 2004). In hypertensive patients, VSMCs from resistance arteries have 
increased ROS generation, and this increase is linked to NADPH oxidase 
(Paravicini & Touyz 2008). Evidence has shown that in SHR and SHRSP rats 
there was an enhanced production of O2ˉ derived by NADPH oxidase, and this 
was associated with the upregulation of p22
phox
 mRNA expression in the aorta 
(Touyz & Schiffrin 2004; Zalba et al. 2001). Furthermore, NOX2 mRNA 
expression in the aorta was found to be greater in SHR compared to the 
normotensive WKY rats (Briones et al. 2011). In vascular cells, SOD is a major 
cellular antioxidant that provides defence against superoxide (∙O2ˉ) (Wassmann et 
al. 2004) There are three isoforms of SOD which have been identified and include 
CuZn-SOD, Mn-SOD and Ec-SOD. The main vascular SOD is Ec-SOD, and is 
produced and secreted by VSMCs (Paravicini & Touyz 2008; Wassmann et al. 
2004). Evidence has shown that in atherosclerotic vessels Ec-SOD expression is 
increased in apoE-deficient mice, a mouse model of atherosclerosis (Fukai et al. 
1998).  
 
Furthermore, the concentration of phytosterols in canola oil has also been 
suggested to be a contributing factor to the shortened lifespan. However, 
conflicting results have shown no clear correlation between the content of 
phytosterols in the diet and tissues and survival time observed (Ohara et al. 2006; 
Tatematsu et al. 2004). Moreover, NaCl loading may be masking the effects of 
dietary phytosterols and canola oil in the SHRSP rat. A recent study showed that 
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dietary phytosterols and phytostanols increase blood pressure in Wistar Kyoto 
rats in the absence of NaCl loading (Chen et al. 2010). Furthermore, research has 
shown that salt intake can induce oxidative stress, and leads to an increase in ∙O2ˉ 
production in SHR and Sprague-Dawley rats (de Cavanagh et al. 2010; Kitiyakara 
et al. 2003). It has been shown that the increase in O2ˉ production in Sprague-
Dawley rats due to salt intake was accompanied by an increase in renal activity 
and mRNA expression of NADPH oxidase, and a decrease in CuZn-SOD and 
MnSOD mRNA expression (Kitiyakara et al. 2003). More research is required to 
investigate the effect of canola oil intake on oxidative damage and to examine the 
changes in the absence of excess dietary salt. This study aimed to determine if 25 
days of canola oil intake in the absence or together with salt loading affects the 
antioxidant and oxidative stress markers in circulation and mRNA expression of 
NADPH oxidase subunits and SOD isoforms in the aorta of SHRSP rats.  
 
 
4.3 Methods  
4.3.1 Animal husbandry and study design 
Approval for this project was granted by the Deakin University Animal Welfare 
Committee (Ethics approval no. A67/09). Forty male SHRSP rats (Deakin 
University, Australia) aged 4 weeks were randomly assigned to either group 1 (n 
= 20) or group 2 (n = 20). Within each group the rats were randomly assigned to a 
control and treatment group and acclimatized for one week. During 
acclimatization they were given a standard pellet diet (Specialty Feeds, Western 
Australia) and water ad libitum. The groups were then fed the following diets 
respectively, a defatted control diet containing 10 wt/wt% soybean oil or a 
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defatted treatment diet containing 10 wt/wt% canola oil (Speciality Feeds, 
Western Australia) for 25 days. Twenty five days was chosen based on our 
pervious study, which showed that the mean life span of the canola oil group was 
85 ± 1.1 days (Papazzo et al. 2011). Given that the rats were 35 days old when 
they started the trial, they were on the diet for a mean of 50 days. We wanted to 
examine weather canola oil intake had an effect on oxidative stress earlier on in 
their life span and, thus, 25 days was chosen as a mid point. The fatty acid 
compositions of the diets are shown in Table 3.1 (Chapter 3). Group 1 was given 
water containing 1% NaCl and group 2 was given tap water throughout the trial. 
The reason for having the group without NaCl in the drinking water is to rule out 
any interfering factor the salt loading may have when analysing the tissue. The 
animals were maintained on a 12 hr light/dark photo-period with a room 
temperature of 21 ± 2°C. Animal body weights, food intake and water 
consumption were determined once a week, while the health of the animals was 
monitored daily. At the end of the 25 days the rats were anaesthetised via intra-
peritoneal injection with lethabarb (50 mg/kg), and blood was collected for 
analysis. Following this, tissue collection was carried out and the aorta was 
removed, washed in saline solution and snap frozen in liquid nitrogen.  
 
4.3.2 Measurement of blood pressure 
Blood pressure was measured weekly and at day 25, and was preformed as 
outlined in Chapter 3, section 3.3.2.  
 
4.3.3 Blood collection and processing 
The blood was collected and processed as outlined in Chapter 3, section 3.3.3. 
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4.3.4 Erythrocyte antioxidant enzymes 
 4.3.4.1 SOD assay 
SOD activity was measured as described in Chapter 3, section 3.3.4.1. 
 
4.3.4.2 Catalase assay 
Catalase activity was measured as described in Chapter 3, section 3.3.4.2. 
 
4.3.4.3 GPx assay 
GPx activity was determined using a commercially available kit (Cayman 
Chemical Company, USA) following manufactures instructions. This assay is 
based on the oxidation of NADPH following the reduction of hydroperoxide. A 
decrease in absorbance at 340 nm results from oxidation of NADPH to NADP+ 
and the rate of this decrease is proportional to the GPx activity in the sample.  
 
Firstly, the following reagents were prepared. The assay buffer dilute was made 
up by reconstituting the vial with 27 ml milli-Q water. The sample buffer dilute 
was made up by adding 2 ml sample buffer provided to 18 ml milli-Q water. The 
GPx control was made up by adding 10 µl of the enzyme to 490 µl sample buffer 
dilute, and stored on ice. The GPx co-substrate mixture was prepared by 
reconstituting the vial with 2 ml milli-Q water and stored at 25°C while carrying 
out the assay. The GPx reaction was set up in a 96 well plate. Firstly, the non-
enzymatic wells were prepared: 120 µl of assay buffer dilute and 50 µl of co-
substrate mixture were added to two wells. Then, the positive control wells were 
prepared: 100 µl of assay buffer dilute, 50 µl of co-substrate mixture and 20 µl of 
diluted GPx control were added to two wells. Next the sample wells were 
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prepared: 100 µl of assay buffer dilute, 50 µl of co-substrate mixture and 20 µl of 
sample were added to two wells. Then to each well 20 µl of cumene 
hydroperoxide was added to initiate the reaction. Next, the plate was placed in a 
microplate analyser (Fusion-Alpha HT, PerkinElmer) and the absorbance read at 
540 nm once every minute for 10 minutes.    
 
4.3.5 Haemoglobin assay 
The antioxidant enzymes were all normalised to haemoglobin, and was measured 
as described in Chapter 3, section 3.3.5. 
 
4.3.6 Lipid peroxidation analysis 
4.3.6.1 MDA  
MDA was determined via HPLC in plasma and erythrocytes and was measured as 
described in Chapter 3, section 3.3.6.1. 
 
4.3.6.2 8-isoprostane 
8-isoprostane was determined in plasma and was measured as described in 
Chapter 3, section 3.3.6.2 
 
4.3.7 Plasma lipids analysis  
 4.3.7.1 Triglycerides  
Plasma triglycerides were determined as described in Chapter 3, section 3.3.7.1. 
  
4.3.7.2 Total cholesterol  
Total cholesterol was determined as described in Chapter 3, section 3.3.7.2. 
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 4.3.7.3 HDL-C  
HDL-C was determined as described in Chapter 3, section 3.3.7.3. 
 
 4.3.7.4 LDL-C 
LDL-C was determined as described in Chapter 3, section 3.3.7.4. 
 
4.3.8 mRNA gene expression analysis  
 4.3.8.1 RNA extraction 
RNA was extracted from the aorta using TRI reagent (Molecular Research 
Centre, USA) following the manufactures instructions. Firstly, all visible fat and 
connective tissue was removed from the aorta and 30 mg of tissue was crushed 
with liquid N2 using a mortar and pestle. This crushed tissue was placed in a 2 ml 
screw top cryovials with 0.5 g homogenisation beads and 1ml of TRI Reagent. 
The cryovials were then placed in the fast-prep homogenizer (MP Biomedicals, 
Australia) for 20 seconds at speed 6 and samples were cooled on ice for 5 
minutes. The homogenisation step in the fast prep for 20 seconds at speed 6 was 
repeated another two times, followed by centrifuging the samples at 12,000 xg for 
10 minutes at 4°C. The supernant was removed and transferred to an eppendorf 
tube. Next, 100 µl of bromochloropropane was added and the samples were 
shaken vigorously for 15 seconds. The samples were stored for 5 minutes at room 
temperature, and then centrifuged at 12,000 xg for 15 minutes at 4°C. The 
supernant (aqueous phase) was transferred to an eppendorf tube and the 
interphase and organic phase was kept and stored at -80°C for protein isolation. 
To the supernant, 500 µl of cold isopropanol and 20 µl of 75% ethanol were 
added, and then the samples were gently shaken for 10 seconds. Next, the 
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samples were stored for 5 minutes at room temperature and then centrifuged at 
12,000 xg for 8 minutes at 4°C. The supernatant was removed and discarded, and 
1ml of cold 75% ethanol was added, and the samples were vortexed for 20 
seconds. Then the samples were centrifuged at 7,500 xg for 5 minutes at 4°C. The 
supernant was then removed and discarded and the RNA pellet was briefly air-
dried for 5 minutes. The RNA was then dissolved in 30 µl of nuclease-free water 
and the solution was passed 5 times through a pipette tip. The RNA samples were 
then quantified using the NanoVue (GE Healthcare Biosciences, Australia).  
 
4.3.8.2 Reverse transcription 
First-strand cDNA was generated from 0.5 µg RNA using the Marligen first 
strand cDNA synthesis kit (Marligen, USA).  Following RNA extraction, the 
samples were placed on ice. Next, a 10 µl reaction was set up in a micro-
eppendorf tube for each sample by adding the following reagents: 2 µl of cDNA 
synthesis, 0.5 µl of reverse transcriptase, 1 µg (0-15 µl) of RNA sample and 
nuclease free water to make up the final volume of 10 µl. Next, the samples were 
placed in a MyCycler Thermal Cycler (Bio-Rad, USA) and the settings were as 
follows: 1 cycle at 22°C for 5 minutes, 1 cycle at 42°C for 30 minutes, 1 cycle at 
85°C for 5 minutes and held at  4°C. The cDNA samples were then stored at -
80°C until analysis of genes.  
 
4.3.8.3 Reverse transcription-real-time PCR measurement of 
mRNA 
Real-time PCR was performed using the iQ5 multicolour real-time PCR detection 
system (Bio-Rad, USA), with PCR reactions carried out using the iQ SYBR 
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Green Supermix (Bio-Rad, USA). The following targeted genes were analysed: 
NOX2, p22
phox
, CuZn-SOD, MnSOD and Ec-SOD, and the primers were all 
obtained from previous published articels (Table 4.1) (Reinehr et al. 2005; Cediel 
et al. 2003; Chabrashvili et al. 2003). 
 
 
Table 4.1: Real-time PCR primer sequences for genes of interest    
Gene Forward primer (5’-3’) Reverse primer (5’-3’) 
NOX 2 TCAAGTGTCCCCAGGTATCC CTTCACTGGCTGTACCAAAGG 
p22phox GCTCATCTGTCTGCTGGAGTA ACGACCTCATCTGTCACTGGA 
CuZn-
SOD 
TGTGTCCATTGAAGATCGTGTGA TCTTGTTTCTCGTGGACCACC 
Mn-SOD TTAACGCGCAGATCATGCA CCTCGGTGACGTTCAGATTGT 
Ec-SOD GGCCCAGCTCCAGACTTGA CTCAGGTCCCCGAACTCATG 
The primers were all obtained from previous published articles and were 
ordered through Geneworks (Australia): NOX2 (Reinehr et al. 2005), 
p22phox (Cediel et al. 2003), CuZn-SOD (Chabrashvili et al. 2003), MnSOD 
(Chabrashvili et al. 2003) and Ec-SOD (Chabrashvili et al. 2003). 
 
 
Firstly, each primer was rehydrated to a final concentration of 100 µM using 
nuclease free water, and then further diluted to 2.4 µM. The cDNA samples prior 
to use were diluted to 1:10 using nuclease free water. RT-PCRs were set up in a 
total reaction of 25 µl that contained 12.5 µl iQ SYBR green supermix, 3.12 µl  
forward primer, 3.12 µl reverse primer, 3.12 µl nuclease free water and 3.12 µl 
cDNA sample. The PCR conditions were: 95°C for 4 minutes, and 40 cycles of 
95°C for 10 seconds, 50°C for 30 seconds and 72°C for 20 seconds, followed by 
95°C for 1 minute and then from 50-95°C read every 1°C, held every 3 seconds.  
Fluorescent emission data were captured and mRNA levels were analysed using 
the critical threshold (CT) value. The relative expression of the gene of interest 
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was calculated using the expression 2
-ΔCT
 and normalised to the cDNA 
concentration, and reported as arbitrary units (Sullivan-Gunn et al. 2011). Briefly, 
the cDNA concentration was quantified using the Quant-iT OliGreen ssDNA 
quantitation reagent kit (Invitrogen, Australia) according to the manufactures 
instructions. Firstly, the oligo standards were prepared as shown in table 4.2. 
Then, to a black 96-well fluoro plate 5 µl of standard or sample were loaded into 
the wells. Following this, 95 µl of 1x TE buffer and 100 µl of 1x ssDNA reagent 
were added to the wells. The plate was incubated at room temperature for 5 
minutes protected from light, and the fluorescence read using a microplate 
analyser (Fusion-Alpha HT, PerkinElmer) set at excitation 485 nm and emission 
538 nm.  
 
 
Table 4.2: Oligo standards  
Tube Standard Concentration 
(ug/ml) 
Volume of 
Standard 
Volume of TE 
buffer 
A 2 1 µl of stock 49 µl 
B 1 10 µl of A  10 µl 
C 0.5 5 µl of A 15 µl 
D 0.25 5 µl of A 35 µl 
E 0.1 16 µl of D 24 µl 
F 0.05 20 µl of E 20 µl 
G 0.025 10 µl of F 10 µl 
H 0 N/A 20 µl 
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4.3.9 Statistical analysis  
Statistical analysis was performed using the SPSS statistical package (version 
17.0, SPSS Inc.) for repeated measures ANOVA and one-way ANOVA. The 
results are represented as mean ± SEM. Comparisons between groups for animal 
body weight, food intake and water intake data were analysed using repeated 
measures ANOVA. A post hoc pair-wise comparison was also carried out. 
Significance was established at the 95% confidence level (P < 0.05). 
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4.4 Results 
4.4.1 Body weight, food intake and water intake 
Body weight of the animals increased gradually over the course of the trial in all 
diet groups (Figure. 4.1). There were no significant differences (P > 0.05) 
between soybean oil and canola oil groups. There were also no significant 
differences (P > 0.05) in food consumption between all dietary groups (Figure 
4.2). The water intake in soybean oil and canola oil groups with salt were 
significantly increased (P < 0.05) between the soybean oil and canola oil groups 
without salt (Figure 4.2).   
 
 
 
Figure 4.1: Mean body weight of SHRSP rats fed canola oil compared 
with soybean oil diet in the absence or presence of NaCl loading.  
Vaules are means ± SEM.  
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Figure 4.2: Food and water intake of SHRSP rats fed canola oil 
compared with soybean oil diet in the absence or presence of NaCl 
loading.  
Values are means ± SEM. ‡P < 0.05 represents a significant difference 
from soybean oil and canola oil no salt groups  
 
 
 
‡ 
 
‡ 
 
‡ 
 
‡ 
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4.4.2 Blood pressure 
Blood pressure increased over time in all diet groups, with significant changes (P 
< 0.05) seen between different groups at days 14, 21 and 25 (Figure 4.3). At day 
14, the blood pressure was significantly increased (P < 0.05) in the canola oil 
group without salt compared to the soybean oil group without salt. At day 21 and 
25, the blood pressure was significantly increased (P < 0.05) in the soybean oil 
group with salt compared to the soybean oil group without salt. Also, at day 25 
the blood pressure was significantly increased (P < 0.05) in the canola oil group 
with salt compared to the canola oil group without salt. 
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Figure 4.3: Mean systolic blood pressure of SHRSP rats fed 25 days 
of canola oil compared with soybean oil in the absence or presence 
of NaCl loading.  
Vaules are means ± SEM. ΩP < 0.05 represents a significant difference 
between soybean oil no salt and soybean oil with salt groups; P < 0.05 
represents a significant difference between canola oil no salt and soybean 
oil no salt groups; #P < 0.05 represents a significant difference between 
canola oil no salt and canola oil with salt groups. 
 
 
 
 
 
Ω 
Ω 
# 
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4.4.3 Antioxidant enzymes and oxidative damage 
Markers of antioxidant status and oxidative damage are represented in Table 4.3. 
In the absence of salt, canola oil ingestion significantly reduced (P < 0.05) the 
activities of RBC SOD and GPx compared with soybean oil alone. The activity of 
RBC GPx was significantly reduced (P < 0.05) in the soybean oil and canola oil 
groups in the presence of salt compared with soybean oil alone. There were no 
significantly differences (P > 0.05) in the activity of catalase between the groups.  
 
Canola oil and soybean oil ingestion with salt loading significantly increased (P < 
0.05) RBC MDA compared to both the canola oil and soybean oil groups without 
salt. Plasma MDA in the canola oil group in the presence of salt was significantly 
higher (P < 0.05) than the canola oil group without salt. There were no 
significantly differences (P > 0.05) in the concentration of 8-isoprostane between 
the groups. 
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Table 4.3: Antioxidant status and oxidative damage in SHRSP rats 
fed 25 days of canola oil compared with soybean oil diet in the 
absence and presence of NaCl loading.  
 Soybean oil  
no salt 
Canola oil 
no salt 
Soybean oil 
salt 
Canola oil 
Salt 
RBC SOD (U/gm 
Hb) 
484.7 ± 76.7 277.6 ± 
51.9* 
337 ± 68.1 354.9 ± 
59.9 
RBC GPx 
(mmol/min/gm 
Hb) 
85.4 ± 4.1 57.2 ± 9* 62.4 ± 8.7* 61.4 ± 7.8* 
RBC Catalase 
(mmol/min/gm 
Hb) 
377.6 ± 40.1 320.4 ± 
36.6 
303.2 ± 33.8 331.1 ± 
42.1 
RBC MDA (µM) 10.2 ± 0.3 10.2 ± 0.3 11.1 ± 0.2‡ 11.1 ± 0.2‡ 
Plasma MDA 
(µM) 
15.9 ± 0.6 14.5 ± 0.4 15.8 ± 1.1 16.4 ± 0.5# 
Plasma 8-
isoprostane 
(pg/ml) 
64.9 ± 8.5 83.2 ± 10.3 86.6 ± 8.7 105.1 ± 
15.5 
Values are means ± SEM; SOD, superoxide dismutase; GPx, glutathione 
peroxidase; MDA, malondialdehyde.  
*P < 0.05 represents a significant difference from soybean oil no salt 
group; #P<0.05 represents a significant difference from canola oil no salt 
group; ‡P<0.05 represents a significant difference from soybean oil and 
canola oil no salt groups 
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4.4.4 Plasma lipids 
Canola oil ingestion alone significantly increased (P < 0.05) the concentration of 
total cholesterol and LDL-C compared to soybean oil alone. LDL-C 
concentration was significantly lower (P < 0.05) in the canola oil group loaded 
with salt compared to the canola oil group without salt. HDL-C concentration was 
significantly higher (P < 0.05) in both the salt loaded groups compared to the no 
salt groups. There were no significant differences (P > 0.05) in the concentration 
of triglycerides between groups (Table 4.4).   
 
 
Table 4.4: Plasma lipids in SHRSP rats fed 25 days of canola oil 
compared with soybean oil diet in the absence and presence of NaCl 
loading. 
 mmol/L 
 
Soybean 
oil  no salt 
Canola oil 
no salt 
Soybean oil 
salt 
Canola oil 
salt 
Total cholesterol 3.1 ± 0.1 3.4 ± 0.1* 3.1 ± 0.1 3.3 ± 0.1* 
 LDL-C  1.4 ± 0.1 1.7 ± 0.1* 2.2 ± 1.3 1.1 ± 0.2# 
HDL-C  1.3 ± 0.1 1.4 ± 0.1 2.3 ± 1.1
‡
 2.3 ± 0.4
‡
 
Triglycerides  1.8 ± 0.1 2 ± 0.1 1.7 ± 0.1 1.9 ± 0.1 
Values are means ± SEM; ‡P<0.05 represents a significant difference 
from soybean oil and canola oil no salt groups; *P<0.05 represents a 
significant difference from soybean oil no salt group; #P<0.05 represents a 
significant difference from canola oil no salt group.    
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4.4.5 mRNA gene expression  
In the absence of salt there were no changes seen in the mRNA expression of 
NOX2 and p22
phox 
(Table 4.5). However, when salt loading was used canola oil 
intake significantly reduced (P < 0.05) NOX2 mRNA expression compared to the 
soybean oil group with salt and the canola oil group without salt. Canola oil 
intake with salt significantly reduced (P < 0.05) p22
phox
 mRNA expression 
compared to the canola oil group without salt.  
 
In the absence of salt, there were no changes seen in the mRNA expression of 
CuZn-SOD, Mn-SOD and EC-SOD (Table 4.5). However, when salt loading was 
used canola oil intake significantly decreased (P < 0.05) CuZn-SOD and Mn-
SOD mRNA expression compared with the soybean oil group with salt and both 
the canola oil and soybean oil groups without salt. EC-SOD mRNA expression 
was significantly reduced in the canola oil group with salt compared with the 
soybean oil group with salt and the canola oil group without salt. 
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Table 4.5: Effect of 25 days of canola oil intake compared to soybean 
oil intake on mRNA expression in the aorta of SHRSP rats in the 
absence and presence of NaCl loading. 
Gene 
mRNA expression (Arbitrary units) 
Soybean oil  
no salt 
Canola oil 
no salt 
Soybean oil 
salt 
Canola oil 
Salt 
p22phox 7.1 ± 2.4 7.6 ± 2 4.2 ± 1.4 2.6 ± 1# 
NOX2 5.3 ± 1.5 9.9 ± 3 9.1 ± 3.6 1.9 ± 0.7†, # 
CuZn-SOD  46.6 ± 19.4 29.7 ± 7.2 22.9 ± 4.5 8.9 ± 2.5†, ‡  
Mn-SOD  126.1 ± 41.2 94.6 ± 20.1 93.5 ± 20.9 37.3 ± 6.7†, ‡  
Ec-SOD  68.9 ± 17.4 82.7 ± 12.1 89.3 ± 17.2 25 ± 1.9†, # 
Values are mean ± SEM. †P < 0.05 represents a significant difference 
between canola oil and soybean oil with salt groups; #P < 0.05 represents 
a significant difference from canola oil no salt group; ‡P<0.05 represents a 
significant difference from soybean oil and canola oil no salt groups. 
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4.5 Discussion 
The data from this study has shown that canola oil ingestion alone decreased the 
activities of SOD and GPx compared with soybean oil by 53 and 33%, 
respectively. These results indicate that canola oil ingestion alone for 25 days 
affects antioxidant enzyme activity. Previous studies have shown that the in the 
canola oil group (with no added salt) the activities of SOD and catalase were 
reduced in the hepatic cytosol of SHR and WKY rats (Natio et al. 2000d; Ohara 
et al. 2008). The present study has also shown that in the presence of salt, both 
canola oil and soybean oil ingestion reduced the activity of GPx compared with 
the soybean oil group without salt. The reduced activity of RBC GPx in the salt 
loaded canola oil group is consistent with our previous findings in chapter 3 
(Papazzo et al. 2011). However, the data from our lifespan study showed that 
canola oil ingestion along with salt loading in SHRSP rats reduced RBC SOD, 
catalase as well as GPx at the end of their life span, mean lifespan of 85 days 
(Papazzo et al. 2011). Supporting evidence shows that there is an association 
between reduced antioxidants and CVD (Kalenikova et al. 2004). In addition, 
previous research has shown an inverse relationship between erythrocyte GPx 
activity and the incidence of CVD.  
 
The present study has also shown that canola oil ingestion with salt loading 
increased the plasma MDA concentration when compared to the canola oil group 
without salt. In addition, RBC MDA concentration was increased in the canola oil 
and soybean oil groups in the presence of salt compared with the non salt groups. 
The increased plasma and RBC MDA concentration indicates an increased 
amount of ROS induced lipid peroxidation, which may be due to the salt loading 
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in combination with the diets. A previous study found an increase in urine MDA 
concentration in Sprague-Dawley rats as a result of salt intake (Kitiyakara et al. 
2003). They found a difference between the low salt (0.03%) and normal salt 
(0.3) groups, and between the low salt and high salt (6%) groups. In addition, 
they also found an increase in urine 8-isoprostane levels as a result of salt intake. 
However, there were no changes found in the 8-isoprostane levels in the present 
study. In a previous study in WKY rats, canola oil ingestion in the absence of 
extra dietary salt decreased lipid peroxide levels in the hepatic cytosol (Ohara et 
al. 2009), while an earlier study showed no change in lipid peroxide levels in the 
hepatic cytosol of SHR with 1% NaCl loading (Ohara et al. 2008). The 
mechanism by which canola oil intake in combination with salt induces MDA is 
currently unknown.  
 
The present study has shown that in the presence of salt, canola oil intake 
decreased the mRNA expression of CuZn-SOD, Mn-SOD and Ec-SOD. The 
decrease in the SOD isoforms indicates a reduced ability to eliminate O2ˉ in the 
presence of canola oil and salt. High salt intake (6%) has been shown to reduce 
renal expression of CuZn-SOD and Mn-SOD in Sprague-Dawley rats (Kitiyakara 
et al. 2003). The present study has also showed that p22
phox
 and NOX2 mRNA 
expression was reduced in the canola oil group with the presence of salt, 
indicating that O2ˉ generated from NADPH oxidase may be decreased. Our 
current study shows for the first time that canola oil intake with salt reduces 
NADPH oxidase subunits and SOD isoforms in the aorta of SHRSP rats after 25 
days of feeding. Evidence has shown that O2ˉ generated from NADPH oxidase is 
increased in hypertension (Paravicini & Touyz 2008). In addition, Kitiyakara et 
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al. (2003) found that salt intake in Sprague-Dawley rats lead to an increase in O2ˉ 
production. This was accompanied by an increase in renal activity and mRNA 
expression of NOX2 and p47
phox
, and a decrease in CuZn-SOD and MnSOD 
mRNA expression (Kitiyakara et al. 2003). However, in the vasculature, there are 
several other sources of ROS, which include: xanthine oxidase, uncoupled nitric 
oxide synthase, lipoxygenase and the mitochondrial respiratory chain (Jiang et al. 
2004; Schulz et al. 2011). In the present study, ROS generation may be coming 
from other sources within the vasculature, and requires further investigation. 
Furthermore, it would have been ideal to examine the protein levels. However, 
there was insufficient protein to carry out the western blotting analysis. A study 
found that plasma Ec-SOD activity was decreased in hypertensive patients, while 
there were no changes found in protein levels (Zhou et al. 2006). Therefore, the 
reduction in Ec-SOD activity is not due to the down regulation of Ec-SOD. In the 
present study, SOD activity was reduced in the canola oil group without salt, 
while there were no changes seen in the mRNA expression of the SOD isoforms.  
 
Previous studies have reported an increase in plasma lipids due to canola oil 
ingestion (Natio et al. 2000b & 2000d; Ohara et al. 2008 & 2009). In the present 
study, canola oil ingestion alone increased the concentration of total cholesterol 
and LDL-C compared with soybean oil alone. When salt loading was used canola 
oil intake increased total cholesterol compared with canola oil without salt. HDL-
C in both the canola oil and soybean oil groups with salt was higher compared 
with the non salt groups. Previous studies in SHR and WKY rats have shown 
increases in total cholesterol and HDL-C with administration of canola oil 
compared to soybean oil (Natio et al. 2000b & 2000d; Ohara et al. 2008 & 2009). 
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It is well established that increased LDL-C is a risk factor for atherosclerosis 
(Diaz et al. 1997). However, in the present study, the combination of canola oil 
and salt intake resulted in a decrease in LDL-C compared with the canola oil 
without salt group. This data is consistent with the results from our lifespan study 
in chapter 3, which showed a decrease in LDL-C, as well as HDL-C and total 
cholesterol in the canola oil group (Papazzo et al. 2011).  There is substantial 
evidence suggesting that high salt intake increases the risk of CVD. However, 
some studies suggest that low salt intake and its adverse effects on blood lipids 
can have a detrimental effect on CVD risk (Harsha et al. 2004). The mechanisms 
by which salt intake affects the blood lipids are not clear. A meta-analysis on 
humans reported that a reduction in salt intake from 200 to 20 mmol/day resulted 
in a significant increase in total cholesterol and LDL-C (Graudal et al. 1998). A 
study by Harsha et al. (2004) found that within each diet (the typical American 
diet (control) and the Dietary Approaches to Stop Hypertension (DASH) diet), 
sodium intake (50, 100 or 150 mmol/d) did not significantly affect the serum 
levels of LDL-C, total cholesterol, HDL-C and triglycerides. However, at each 
sodium concentration, LDL-C, HDL-C and total cholesterol were lower in the 
DASH diet compared to the American control diet (Harsha et al. 2004). Taken 
together these results suggest that a diet low in salt leads to an increase in LDL-C.  
    
The results of the present study show an increase in systolic blood pressure in 
both the canola oil and soybean oil groups with salt compared to the dietary 
groups without salt at the end of the feeding trial. The association between salt 
intake and hypertension is well known, which is evident in the present the study.  
Evidence indicates that canola oil intake has an effect on blood pressure in the 
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SHRSP rat and its related strains. However, the blood pressure in the canola oil 
groups was not consistently different from soybean oil. Our lifespan study 
showed that blood pressure in the canola oil group was not different from 
soybean oil. A study by Huang et al. (1996) observed no significant change in 
systolic blood pressure in the canola oil group compared to the soybean oil group 
at 4 and 8 weeks of age (Huang et al. 1996). Another study by Ratnayake et al. 
(2000a) found no significant differences in the SBP among different dietary 
groups in SHRSP rats (Ratnayake et al. 2000a). Taken together these results 
suggest that canola oil intake in the presence or absence of salt does not affect 
blood pressure. Therefore, the life shortening effect of canola oil may not be 
directly due to an increase in blood pressure.   
 
In conclusion, canola oil ingestion in the absence of dietary salt decreased the 
activities of RBC SOD and GPx, and increased both total cholesterol and LDL-C, 
which are risk factors for CVD. However, the combination of canola oil and 
dietary salt intake resulted in an increase in plasma MDA, a decrease in LDL-C, 
and a decrease in NADPH oxidase subunits and SOD aortic expression when 
compared to canola oil intake alone. ROS generation may be coming from other 
sources within the vasculature. The increase in RBC and plasma MDA, with a 
decrease in RBC GPx and SOD mRNA expression may indicate an elevation in 
oxidative stress. More research is required to determine if canola oil intake in the 
absence or presence of salt leads to oxidative stress and altered vascular changes 
such as endothelial dysfunction in a longer duration study.  
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CHAPTER 5  
The effect of 50 days of canola oil ingestion on 
oxidative stress in the vasculature and endothelial 
function in SHRSP rats 
 
 
5.1 Abstract 
Background  
This study aimed to determine if 50 days of canola oil intake in the absence of 
excess dietary salt or together with salt loading effects: (1) the antioxidant and 
oxidative stress markers in the circulation, (2) aortic mRNA expression of 
NADPH oxidase subunits and SOD isoforms and (3) endothelial function in 
SHRSP rats.  
Methods 
Male SHRSP rats were fed a defatted control diet containing 10 wt/wt% soybean 
oil or a defatted treatment diet containing 10 wt/wt% canola oil, and given tap 
water or water containing 1% NaCl for 50 days. Blood was collected at the end of 
study for analysis of RBC antioxidant enzymes, RBC and plasma MDA, plasma 
8-isoprostane and plasma lipids. The aorta was removed and the mRNA 
expression of NOX2, p22
phox
, CuZn-SOD, Mn-SOD and EC-SOD were 
determined. The contractile responses to norepinephrine, and endothelium-
dependent and -independent vasodilating responses to ACh and SNP, 
respectively, were measured in thoracic aortic rings. Male WKY rats were used as 
a normotensive control to assess endothelial function and were fed 10 wt/wt% 
soybean oil for 50 days.  
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Results 
In the absence of salt, canola oil increased RBC SOD, total cholesterol and 
triglycerides, p22
phox
, NOX2 and CuZn-SOD mRNA expression and decreased 
RBC GPx. In the presence of salt, canola oil reduced RBC SOD, catalase, LDL-
C, and p22
phox
 mRNA expression compared with canola oil alone, whereas 
plasma MDA was reduced and LDL-C was higher compared with soybean oil 
with salt. In addition, RBC MDA was significantly increased in the canola oil 
group with salt compared to the soybean oil group with salt and to the non salt 
groups. In the presence of salt, the canola oil group had significantly reduced 
endothelium-dependent vasodilating responses to ACh and contractile responses 
to norepinephrine compared with the canola oil group without salt and to the 
WKY rats.  
Conclusion  
In conclusion, these results indicate that canola oil alone increases p22
phox
 and 
NOX2 mRNA expression suggesting an increase in O2ˉ generation. However, 
canola oil ingestion in combination with salt leads to endothelial dysfunction.  
  
 
5.2 Introduction 
In the study described in the previous chapter, short-term ingestion (25 days) of 
canola oil in the absence of excess dietary salt resulted in a decrease in RBC SOD 
and GPx, and an increase in LDL-C and total cholesterol, which are risk factors 
for CVD. However, in the presence of salt, canola oil ingestion lead to an 
increase in MDA and a decrease in NAPDH oxidase and SOD aortic mRNA 
expression. Our lifespan study described in chapter 3, found that canola oil 
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ingestion decreased RBC antioxidant enzymes and increased RBC MDA 
(Papazzo et al. 2011). However, the effect of canola oil ingestion in the absence 
or presence of excess dietary salt for a longer period of time on oxidative stress 
has not been examined previously in SHRSP rats.  
 
An increase in ROS activity contributes to the impaired regulation of 
physiological processes within the vascular wall, which leads to structural and 
functional changes observed in hypertension (Zalba et al. 2001). Recent research 
has shown that endothelial dysfunction is an early sign of CVD (Davies 2009).  
Increased ROS activity in the vasculature can lead to a decrease in NO 
bioavailability and impaired endothelium-dependent vasorelaxation, which results 
in endothelial dysfunction (Berry et al. 2001; Zalba et al. 2001; Datla & 
Griendling 2010). An excess of vascular ROS generation or reduced levels of 
antioxidants has been associated with the pathogenesis of endothelial dysfunction 
in SHRSP rats (Ulker et al. 2003).  
 
This study aimed to determine if 50 days of canola oil intake in the absence of 
excess dietary salt or together with salt loading affects: (1) the antioxidant and 
oxidative stress markers in the circulation, (2) the mRNA expression of NADPH 
oxidase subunits and SOD isoforms in the aorta, and (3) endothelial function in 
SHRSP rats.   
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5.3 Materials and methods 
5.3.1 Animal husbandry and study design 
5.3.1.1 Fifty day treatment experiment  
Forty male SHRSP rats (Deakin University, Australia) aged 4 weeks were 
randomly assigned to either group 1 (n = 20) or group 2 (n = 20). Within each 
group the rats were randomly assigned to a control and treatment group and 
acclimatized for one week. During acclimatization they were given a standard 
pellet diet (Specialty Feeds, Western Australia) and water ad libitum. The groups 
were the fed the following diets respectively, a defatted control diet containing 10 
wt/wt% soybean oil or a defatted treatment diet containing 10 wt/wt% canola oil 
(Speciality Feeds) for 50 days. Our previous study examined the effect of 25 days 
of canola oil ingestion, therefore, 50 days was chosen to observe the use of canola 
oil ingestion for a longer period of time. In addition, 50 days was also chosen 
based on our pervious study, which showed that the mean lifespan of the canola 
oil group was 85 ± 1.1 days (Papazzo et al. 2011). Given that the rats were 35 
days old when they started the trial, they were on the diet for a mean of 50 days. 
The fatty acid composition of the diets is shown in Table 3.1 (Chapter 3). Group 
1 was given water containing 1% NaCl and group 2 was given tap water 
throughout the trial. The reason for having the group without NaCl in the drinking 
water is to rule out any interfering factor the salt loading may have when 
analysing the tissue. The animals were maintained on a 12 hr light/dark photo-
period with a room temperature of 21 ± 2°C. Animal body weights, food intake 
and water consumption were determined once a week, while the health of the 
animals was monitored daily. At the end of the 50 days the rats were 
anaesthetised via intra-peritoneal injection with lethabarb (50 mg/kg), and blood 
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was collected for analysis. The aorta was then removed, washed in saline solution 
and snap frozen in liquid nitrogen.  
 
5.3.1.2 Vascular function experiment  
Forty male SHRSP rats and ten male WKY rats (Deakin University, Australia) 
aged 4 weeks were acclimatized for one week. During acclimatization they were 
given a standard pellet diet (Specialty Feeds, Western Australia) and water ad 
libitum. After the acclimatization period, the SHRSP rats were the fed the 
following diets respectively, a defatted control diet containing 10 wt/wt% 
soybean oil or a defatted treatment diet containing 10 wt/wt% canola oil 
(Speciality Feeds) for 50 days. The WKY rats were fed 10 wt/wt% soybean oil 
control diet for 50 days and given tap water. The WKY rats were used as a 
normotensive control to assess endothelial function. The animals were maintained 
on a 12 hr light/dark photo-period with a room temperature of 21 ± 2°C. The 
health of the animals was monitored daily. At the end of the 50 days the rats were 
anaesthetised via intra-peritoneal injection with sodium pentobarbitone (50 
mg/kg). The aorta was removed and used for the isolated aortic rings experiment.     
 
5.3.2 Measurement of blood pressure 
Blood pressure was measured weekly, and was preformed as outlined in Chapter 
3, section 3.3.2. 
 
5.3.3 Blood collection and processing 
The blood was collected and processed as outlined in Chapter 3, section 3.3.3. 
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5.3.4 Erythrocyte antioxidant enzymes 
 5.3.4.1 SOD assay 
SOD activity was measured as described in Chapter 3, section 3.3.4.1. 
 
5.3.4.2 Catalase assay 
Catalase activity was measured as described in Chapter 3, section 3.3.4.2. 
5.3.4.3 GPx assay 
GPx activity was measured as described in Chapter 4, section 4.3.4.3.  
 
5.3.5 Haemoglobin assay 
The antioxidant enzymes were all normalised to haemoglobin, and was measured 
as described in Chapter 3, section 3.3.5. 
 
5.3.6 Lipid peroxidation analysis 
5.3.6.1 MDA  
MDA was determined via HPLC in plasma and erythrocytes and was measured as 
described in Chapter 3, section 3.3.6.1 
 
5.3.6.2 8-isoprostane 
8-isoprostane was determined in plasma and was measured as described in 
Chapter 3, section 3.3.6.2 
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5.3.7 Plasma lipids analysis 
 5.3.7.1 Triglycerides  
Plasma triglycerides were determined as described in Chapter 3, section 3.3.7.1. 
  
5.3.7.2 Total cholesterol  
Total cholesterol was determined as described in Chapter 3, section 3.3.7.2. 
 
 5.3.7.3 HDL-C  
HDL-C was determined as described in Chapter 3, section 3.3.7.3. 
 
 5.3.7.4 LDL-C 
LDL-C was determined as described in Chapter 3, section 3.3.7.4. 
 
5.3.8 mRNA gene expression analysis  
 5.3.8.1 RNA extraction 
RNA extraction from the aorta was performed as previously described in Chapter 
4, section 4.3.8.1.  
 
5.3.8.2 Reverse transcription 
Reverse transcription was carried out as previously described in Chapter 4, 
section 4.3.8.2. 
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5.3.8.3 Reverse transcription-real-time PCR measurement of 
mRNA 
Real-time PCR was performed as previously described in Chapter 4, section 
4.3.8.3.  
 
5.3.9 Isolated aortic rings 
After the aorta was removed, it was placed immediately into Tydrode solution 
(containing in mM: 136.9 NaCl, 5.4 KCl, 1.05 MgCl2, 1.8 CaCl2, 22.6 NaHCO3, 
0.42 NaH2PO4, 5.5 glucose, 0.28 ascorbic acid and 0.1 EDTA) bubbled with 
carbogen (95% oxygen and 5% carbon dioxide). All visible fat and connective 
tissue was removed. The aorta was then cut into three 4 mm rings and suspended 
in an organ bath chamber and bathed in Tydrode solution bubbled with carbogen. 
The organ baths are water jacketed and the water temperature was maintained at 
35°C ± 0.5. Prior to the introduction of each of the vasoactive substances, the 
aortic rings were equilibrated for 1 hour in Tydrode solution with a resting 
tension of 10 mN.  During the equilibration period the Tydrode solution was 
changed every 15 minutes. A cumulative concentration-response curve was 
performed for norepinephrine (final bath concentration 10
-9
 to 10
-4
 M) on one 
arotic ring to assess vasoconstriction. After a submaximal contraction to 
norepinephrine was reached in the other two arotic rings, endothelium-dependent 
and -independent vasodilation was assessed using ACh and SNP, respectively 
(final bath concentration 10
-9
 to 10
-4
 M). Force of contraction in the aorta was 
measured isometrically with force transducers (FT03C, Grass, USA) connected 
via amplifiers to a computer via a LabChart system (AD Instruments, Australia). 
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5.3.10 Statistical analysis  
Statistical analysis was performed using the SPSS statistical package (version 
17.0, SPSS Inc.) for repeated measures ANOVA and one-way ANOVA. The 
results are represented as mean ± SEM. Comparisons between groups for animal 
body weight, food intake and water intake data were analysed using repeated 
measures ANOVA. A post hoc pair-wise comparison was also carried out. 
Significance was established at the 95% confidence level (P < 0.05).  
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5.4 Results 
5.4.1 Body weight, food intake and water intake 
Body weight of the SHRSP rats increased gradually over the course of the trial in 
all diet groups. There were no significant differences (P > 0.05) between soybean 
oil and canola oil groups (Figure 5.1). There were also no significant differences 
(P > 0.05) in food consumption between all dietary groups. The water intake in 
soybean oil and canola oil groups with salt were significantly increased (P < 0.05) 
between the soybean oil and canola oil groups without salt (Figure 5.2).  
 
 
 
 
Figure 5.1: Mean body weight of SHRSP rats fed canola oil compared 
with soybean oil diet in the absence or presence of NaCl loading.  
Vaules are means ± SEM.  
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Figure 5.2: Food and water intake of SHRSP rats fed canola oil 
compared with soybean oil diet in the absence or presence of NaCl 
loading.  
Values are means ± SEM. ‡P < 0.05 represents a significant difference 
from soybean oil and canola oil no salt groups. 
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5.4.2 Blood pressure 
Blood pressure increased over time in all dietary groups (Figure 5.3). At day 14, 
the blood pressure was significantly increased (P < 0.05) in the canola oil group 
without salt compared to the soybean oil group without salt. From day 21 to day 
50, the blood pressure was significantly increased (P < 0.05) in the soybean oil 
group with salt compared to the soybean oil group without salt. Also, from day 28 
to day 50, the blood pressure was significantly increased (P < 0.05) in the canola 
oil group with salt compared to the canola oil group without salt. At day 42, the 
blood pressure was significantly increased (P < 0.05) in the canola oil group with 
salt compared to the soybean oil group with salt. 
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Figure 5.3: Mean systolic blood pressure of SHRSP rats fed 50 days 
of canola oil compared with soybean oil in the absence or presence 
of salt.  
Vaules are means ± SEM. †P <0.05 represents a significant difference 
between canola oil no salt and soybean oil no salt; #P<0.05 represents a 
significant difference between canola oil no salt and canola oil with salt; 
*P<0.05 represents a significant difference between soybean oil no salt 
and soybean oil with salt; ‡ P<0.05 represents a significant difference 
between canola oil with salt and soybean oil with salt. 
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5.4.3 Antioxidant enzymes and oxidative damage 
Markers of antioxidant status and oxidative damage are represented in Table 5.1. 
In the absence of salt, canola oil ingestion significantly increased (P < 0.05) the 
activity of RBC SOD and significantly reduced (P < 0.05) the activity of RBC 
GPx compared with soybean oil alone. In the presence of salt, RBC SOD and 
catalase were significantly reduced (P < 0.05) in the canola oil group compared 
with the canola oil group without salt. RBC GPx and catalase were significantly 
reduced (P < 0.05) in the soybean oil group with salt compared with the soybean 
oil group without salt.    
 
Canola oil ingestion with salt significantly increased (P < 0.05) RBC MDA 
compared to the soybean oil group with salt and to the non salt groups. Plasma 
MDA in the canola oil group with salt was significantly lower (P < 0.05) 
compared to the soybean oil group with salt. Soybean oil intake with salt 
significantly increased (P < 0.05) plasma 8-isoprostane compared to the canola 
oil group with salt and to the non salt groups.  
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Table 5.1: Antioxidant status and oxidative damage in SHRSP rats fed 50 
days of canola oil compared with soybean oil diets in the absence and 
presence of NaCl loading.  
 Soybean oil  
no salt 
Canola oil 
no salt 
Soybean oil 
salt 
Canola oil 
salt 
RBC SOD 
(U/gm Hb) 
281.6 ± 48.1 425.7 ± 52.7* 297.9 ± 45.1  290.7 ± 31.2# 
RBC GPx 
(mmol/min/gm 
Hb) 
140 ± 8.6 110 ± 8.6* 74.1 ± 12.5* 96.6 ± 17.1 
RBC Catalase 
(mmol/min/gm 
Hb) 
455.2 ± 54.1 381.5 ± 35.1 302 ± 26.8* 216.2 ± 36.2*, # 
RBC MDA 
(µM) 
14.7 ± 1.3 17.7 ± 2.2 17.6 ± 1.9 34.5 ± 5.8†, ‡ 
Plasma MDA 
(µM) 
18.8 ± 0.6 18.8 ± 1.6 19.6 ± 0.6 16.1 ± 0.8† 
Plasma 8-
isoprostane 
(pg/ml) 
110.4 ± 8.9 97.7 ± 15.3 155.2 ± 17.9†, ‡ 87.6 ± 10.9 
Values are means ± SEM; SOD, superoxide dismutase; GPx, glutathione 
peroxidase; MDA, malondialdehyde.  
†P < 0.05 represents a significant difference between canola oil and soybean oil 
with salt groups; #P < 0.05 represents a significant difference from canola oil no 
salt group; ‡P < 0.05 represents a significant difference from soybean oil and 
canola oil no salt groups. *P < 0.05 represents a significant difference from 
soybean oil no salt group 
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5.4.4 Plasma lipids 
Canola oil ingestion alone significantly increased (P < 0.05) the concentration of 
total cholesterol and triglycerides compared to soybean oil alone. Total 
cholesterol was significantly higher (P < 0.05) in the canola oil loaded with salt 
compared to the canola oil group without salt. LDL-C was significantly increased 
(P < 0.05) in the canola oil group with salt compared to both the canola oil and 
soybean oil groups without salt. The concentration of triglycerides was 
significantly lower in the canola oil group with salt compared to the soybean oil 
group with salt. In the soybean oil group in the presence of salt, the concentration 
of total cholesterol, LDL-C, HDL-C and triglycerides were significantly higher (P 
< 0.05) compared to soybean oil alone (Table 5.2).   
 
 
Table 5.2: Plasma lipids in SHRSP rats fed 50 days of canola oil 
compared with soybean oil diets in the absence and presence of 
NaCl loading. 
 mmol/L 
 Soybean oil  
no salt 
Canola oil 
no salt 
Soybean oil 
salt 
Canola oil 
salt 
Total cholesterol 2.8 ± 0.1 3.2 ± 0.1* 4.2 ± 0.3* 3.5 ± 0.2† 
 LDL-C 1 ± 0.04 1.2 ± 0.1 2.1 ± 0.2* 1.7 ± 0.2‡ 
HDL-C 1.4 ± 0.04 1.5 ± 0.04 1.6 ± 0.06* 1.6 ± 0.06 
Triglycerides 1.5 ± 0.1 2.1 ± 0.1* 2 ± 0.2* 2 ± 0.1* 
Values are means ± SEM; *P < 0.05 represents a significantly difference 
from soybean oil no salt group; †P < 0.05 represents a significant 
difference between canola oil and soybean oil with salt groups; ‡P < 0.05 
represents a significant difference from soybean oil and canola oil no salt 
groups. 
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5.4.5 mRNA gene expression  
In the absence of salt, canola oil intake significantly increased (P < 0.05) p22
phox
 
and NOX2 mRNA expression compared to soybean oil alone (Table 5.3). In the 
presence of salt, canola oil and soybean oil intake significantly reduced (P < 0.05) 
the mRNA expression of p22
phox
 compared to the canola oil group without salt. 
NOX2 mRNA expression was significantly increased (P < 0.05) in the soybean 
oil group with salt compared to both the soybean oil and canola oil groups 
without salt.  
 
CuZn-SOD mRNA expression was significantly increased in both the canola oil 
and soybean oil groups with salt (P < 0.05) compared to the soybean oil group 
without salt. There were no changes seen in the mRNA expression of Mn-SOD 
and Ec-SOD between groups.  
 
 
Table 5.3: Effect of 50 days of canola oil intake compared to soybean 
oil intake on mRNA expression in the aorta of SHRSP rats in the 
absence and presence of NaCl loading. 
Gene 
mRNA expression (Arbitrary units) 
Soybean oil  
no salt 
Canola oil 
no salt 
Soybean oil 
salt 
Canola oil 
Salt 
p22phox 7.6 ± 1.4 21.8 ± 3.5* 8.9 ± 2# 11.5 ± 4.1# 
NOX2 1.4 ± 0.6 12.1 ± 5* 65 ± 22.6‡ 26.2 ± 6 
CuZn-SOD  22.2 ± 5.1 39.2 ± 7.8* 60.5 ± 15.9* 54.9 ± 15* 
Mn-SOD  76 ± 19.9 56.7 ± 9.1 100 ± 18.6 95.2 ± 22.2 
Ec-SOD  7.1 ± 1.9 4.4 ± 0.9 8.1 ± 1.7 7.6 ± 1.8 
Values are mean ± SEM. ‡P < 0.05 represents a significant difference 
from soybean oil and canola oil no salt groups; *P < 0.05 represents a 
significant difference from soybean oil no salt group; #P < 0.05 represents 
a significant difference from canola oil no salt group. 
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5.4.6 Vascular responses 
Canola oil fed SHRSP rats with salt intake showed significantly reduced (P < 
0.05) contractile responses to norepinephrine compared to SHRSP rats fed only 
canola oil (Figure 5.4A). The contractile responses to norepinephrine were 
significantly greater (P < 0.05) in the SHRSP rats fed only canola oil compared to 
the SHRSP rats fed only soybean oil. Contractile responses to norepinephrine 
were significantly greater (P < 0.05) in the WKY rats compared to the SHRSP 
rats fed canola oil and soybean oil in the presence of salt and to the soybean oil 
only group.  
 
Relaxation responses to SNP were not significantly different between groups (P > 
0.05) (Figure 5.4B).  The ACh dilating responses were not significantly different 
(P > 0.05) between the SHRSP rats fed canola oil and soybean oil without salt 
(Figure 5.4C). Canola oil fed SHRSP rats with salt loading showed a significantly 
impaired (P < 0.05) endothelium-dependent relaxation response of the thoracic 
aorta compared to the canola oil only group and WKY rats.  
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Figure 5.4: Cumulative concentration-response curves for 
norepinephrine (A), SNP (B) and ACh (C) in aortic rings from SHRSP 
and WKY rats.  
Values are mean ± SEM. *P < 0.05 represents a significant difference 
from soybean oil no salt; †P < 0.05 represents a significant different from 
canola oil and soybean oil with salt;
 #
P < 0.05 represents a significant 
difference from canola oil no salt; ‡P < 0.05 represents a significant 
difference from canola oil with salt; ΩP < 0.05 represents a significant 
difference from all dietary groups; P < 0.05 represents a significant 
difference from WKY rats. 
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5.5 Discussion  
In the present study, canola oil ingestion alone increased the activity of RBC 
SOD and reduced RBC GPx compared with the soybean oil group. Similar results 
have also been found in a study by Ohara et al. 2009, in which the activities of 
GPx and catalase were reduced in the liver of WKY rats following canola oil 
ingestion. Furthermore, our previous study in chapter 4 found that 25 days of 
canola oil ingestion alone decreased the activities of RBC SOD and GPx. The 
results from the present study suggest that 50 days of canola oil ingestion alone 
leads to changes in antioxidant levels. The present study has also shown that in 
the presence of salt, canola oil ingestion reduced the activities of RBC SOD and 
catalase compared with the canola oil group without salt. The soybean oil group 
in the presence of salt also showed reduced activities of RBC SOD and catalase 
compared to the soybean oil group without salt. This data is consistent with our 
lifespan study data in chapter 3, which showed a decrease in RBC SOD and 
catalase, however, RBC GPx was also reduced. Furthermore, the results from the 
lifespan study did not find any changes in the activities of the RBC antioxidants 
in the soybean oil group. RBCs are under constant exposure to ROS and oxidative 
stress due to their role in transporting oxygen and carbon dioxide, and their 
increased content of heme iron (Cimen 2008). Therefore, the 
oxidative/antioxidant balance can become altered. Supporting evidence shows 
that there is an association between reduced antioxidants and CVD (Kalenikova 
et al. 2004). In addition, previous research has shown an inverse relationship 
between erythrocyte GPx activity and the incidence of CVD (Blankenberg et al. 
2003).  
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The present study has also shown that canola oil ingestion in combination with 
salt leads to an increase in RBC MDA compared to all the other dietary groups. 
Whereas, plasma MDA was reduced in the canola oil group with salt compared to 
the soybean oil group with salt. This result is consistent with our lifespan study 
data in chapter 3, which showed a decrease in plasma MDA in the canola oil 
group compared to the soybean oil group. The mechanism by which canola oil 
along with salt intake leads to a decrease in plasma MDA is currently unknown. 
Our previous study found that short term intake (25 days) of canola oil resulted in 
an increase in both RBC and plasma MDA. The present study has also shown that 
soybean oil ingestion in combination with salt lead to an increase in plasma 8-
isoprostane compared to all the other dietary groups. In the present study the 
increase in RBC MDA and plasma 8-isoprostane indicates an increase in lipid 
peroxidation. Salt intake may be a contributing factor to the changes seen, as 
there were no changes observed in the markers of oxidative stress in the diets 
without salt intake. A previous study observed an increase in urine MDA 
concentration in Sprague-Dawley rats as a result of salt intake (Kitiyakara et al. 
2003). They found a difference between the low salt (0.03%) and normal salt 
(0.3%) groups, and between the low salt and high salt (6%) groups. In addition, 
they also found an increase in urine 8-isoprostane levels as a result of salt intake. 
 
Evidence has shown that NADPH oxidase derived O2
−
 is enhanced in 
hypertension (de Cavanagh et al. 2010; Kitiyakara et al. 2003). In the present 
study, canola oil ingestion in the absence of salt increased p22
phox
 and NOX2 
mRNA expression compared to soybean oil alone. This data suggests that O2
− 
generated from NADPH oxidase is elevated in the presence of canola oil alone. In 
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addition, canola oil ingestion in the presence of salt reduced p22
phox
 mRNA 
expression compared to the canola oil group without salt. However, NOX2 
mRNA expression was increased in the soybean oil group with salt intake 
compared to the non-salt groups. The previous study in chapter 4 showed that 25 
days of canola oil ingestion with salt reduced the mRNA expression of p22
phox
 
compared to the canola oil group without salt, which is consistent with the results 
from the present study. However, in the 25 day study, NOX2 mRNA expression 
was also found to be reduced in the canola oil group with salt, which was not 
evident in the present study.  A study by Kitiyakara et al. (2003) found that salt 
intake in Sprague-Dawley rats lead to an increase in O2ˉ production. This was 
accompanied by an increase in renal activity and mRNA expression of NOX2 and 
p47
phox
, and a decrease in CuZn-SOD and Mn-SOD mRNA expression 
(Kitiyakara et al. 2003). However, the results from the present study show that 
canola oil ingestion without salt, and both the soybean oil and canola oil groups 
with salt increased the mRNA expression of CuZn-SOD compared to soybean oil 
alone. The increase in the mRNA expression of CuZn-SOD along with an 
increase in RBC SOD in the canola oil group without salt may be an adaptive 
response to an increase in O2
− 
generation. The previous study in chapter 4 showed 
that 25 days of canola oil ingestion with salt reduced the mRNA expression of 
CuZn-SOD, Mn-SOD and Ec-SOD, which is not evident in the present study. 
There were no changes found in Mn-SOD and Ec-SOD in the present study. 
Furthermore, in the present study, ROS generation in the canola oil group in the 
presence of salt may be coming from other sources within the vasculature, such as 
xanthine oxidase, uncoupled nitric oxide synthase, lipoxygenase and the 
mitochondrial respiratory chain (Jiang et al. 2004; Schulz et al. 2011).  
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The results from the present study show that contractile responses to 
norepinephrine were reduced in the canola oil group with salt compared to the 
canola oil only group, indicating smooth muscle cell contractile dysfunction. In 
addition, in the present study the contractile responses were greater in the SHRSP 
rats fed only canola oil compared to the soybean oil only group. Also, the WKY 
rats had greater contractile responses compared to the soybean oil only group and 
to both the canola oil and soybean oil groups with salt. These results show that 
SHRSP rats have reduced smooth muscle contractile function; however, the 
intake of canola oil alone may result in reducing contractile dysfunction. 
Furthermore, a study by Natio et al. (2000c) found that in SHRSP rats, in which 
salt loading was not used, the contractile responses in isolated mesenteric 
vascular bed to norepinephrine and to other agonists such as angiotensin II, 
arachidonic acid, ATP, endothelin-1 or serotonin were not different between the 
canola oil and soybean oil group after 4 weeks of feeding. The results from the 
present study also show that canola oil ingestion in combination with salt leads to 
a decrease in the endothelium-dependent vasodilating response to ACh compared 
to canola oil ingestion alone. The results suggest that salt intake in combination 
with canola oil is leading to endothelial dysfunction. A study found that in SHR 
and WKY rats the endothelium-dependent and endothelium-independent 
vasodilating responses to ACh and SNP, respectively, were not different between 
the canola oil and soybean oil groups in each strain following salt loading (Natio 
et al. 2000b). These results are consistent with the results found in the present 
study, as there were no changes found in the vasodilating responses to ACh and 
SNP between the canola oil and soybean oil groups with salt. However, the 
vasodilating responses to ACh were reduced in the canola oil group with salt 
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compared with the WKY rats. In addition, studies have shown an association 
between high salt intake and endothelial dysfunction (Bragulat & de la Sierra 
2002). A study has found that long term high salt intake caused a reduction in 
endothelium-dependent vasorelaxation in salt-sensitive rats (Li et al. 2009). 
Evidence has shown that in Sprague-Dawley rats, high salt intake leads to 
endothelial dysfunction by reducing the concentration of NO and eNOS activity 
(Datla & Griendling 2010). It is well established that ROS interacts with 
endothelial NO, thus decreasing the vasodilating response of blood vessels. 
However, p22
phox
 mRNA expression was reduced in the canola oil group with 
salt, suggesting a decrease in NADPH oxidase derived O2
−
 generation. The 
interaction between salt intake and canola oil is not clearly understood, however, 
it seems that canola oil in combination with salt leads to reduced smooth muscle 
contractile function and impaired endothelium-dependent vasorelaxation.     
 
Previous studies have reported an increase in plasma lipids due to canola oil 
ingestion (Natio et al. 2000b & 2000d; Ohara et al. 2008a & 2009). Canola oil is 
considered to provide protective cardiovascular effects due to its favourable fatty 
acid composition (Ratnayake et al. 2000b). However, in the present study, canola 
oil ingestion alone increased the concentration of total cholesterol and 
triglycerides compared with soybean oil alone. These results are consistent with 
the results from the previous study in chapter 4, which showed that short term 
ingestion of canola oil alone increased total cholesterol as well as LDL-C. 
Evidence has shown that dietary salt restriction from 10g to 2g per day for 5 days 
in patients with essential hypertension significantly increased total cholesterol 
and LDL-C (Sharma et al. 1990). Furthermore, there is an associated between 
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increased concentrations of plasma total cholesterol, triglycerides and LDL-C and 
the development of CVD such as atherosclerosis (Ballantyne et al. 2005). In 
addition, the present study has also shown that canola oil ingestion in the 
presence of salt increased total cholesterol and LDL-C, where as the 
concentration of triglycerides was reduced. Our life span study showed that 
canola oil ingestion following salt loading reduced total cholesterol and LDL-C 
compared with soybean oil (Papazzo et al. 2011). In addition, the results from the 
present study also show that soybean oil in the presence of salt increased total 
cholesterol, LDL-C, HDL-C and triglycerides compared to soybean oil alone. In 
the present study, salt intake is having an interacting effect on the plasma lipids, 
as the increase in the total cholesterol and LDL-C is common in both the canola 
oil and soybean oil groups with salt loading. The mechanism to explain the salt 
interaction and the increase in plasma lipids is unknown, and warrant further 
investigation.    
 
The association between salt intake and hypertension is well known (Taylor et al. 
2011), which is evident in the present the study. The results of the present study 
show an increase in systolic blood pressure in both the canola oil and soybean oil 
groups with salt compared to the dietary groups without salt at the end of the 
feeding trial. Evidence indicates that canola oil intake has an effect on blood 
pressure in the SHRSP rat and its related strains (Natio et al. 2000, 2000b & 
2003). However, the blood pressure in the canola oil group was not consistently 
different from soybean oil. The results from the previous studies in chapter 3 and 
4 also show that the blood pressure in the canola oil group is not different to the 
soybean oil group. Taken together these results suggest that canola oil intake in 
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the presence or absence of salt does not affect blood pressure. This is also 
supported by other studies, which have shown no significant changes in blood 
pressure between the canola oil and soybean oil groups in SHRSP rats (Huang et 
al. 1996; Ratnayake et al. (2000a). 
 
In conclusion, canola oil intake alone increased p22
phox
 and NOX2 mRNA 
expression, suggesting an increase in O2ˉ generation. In addition, canola oil 
ingestion alone increased RBC SOD, total cholesterol and triglycerides and 
decreased RBC GPx, which are risk factors for CVD. Canola oil in combination 
with salt intake increased RBC MDA, total cholesterol and LDL-C and decreased 
RBC SOD, catalase, plasma MDA and p22
phox
 mRNA expression. Furthermore, 
canola oil intake with salt loading significantly impaired endothelial function in 
SHRSP rats when compared to canola oil intake alone.  
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CHAPTER 6  
 Overall conclusions 
 
 
6.1 Summary of the major findings 
The overall objectives of the thesis were to determine the effect of canola oil 
ingestion on oxidative stress in the vasculature and endothelial function in 
SHRSP rats. Evidence has shown that ingestion of canola oil as the sole dietary 
fat source (added at 10 wt/wt% to standard rat chow) shortens the lifespan of 
SHRSP rats. The mechanism by which canola oil reduces lifespan is currently 
unknown. However, recent studies suggest that one of key mechanisms leading to 
the shortened lifespan in SHRSP rats is via the acceleration of hypertension-
related deterioration of organs (Natio et al. 2003; Ohara et al. 2006). The damage 
and deterioration of organs may be exacerbated by oxidative stress due to canola 
oil intake. Growing evidence has found that oxidative stress leads to vascular 
damage and plays a critical role in the pathogenesis of CVD (Berry et al. 2001). 
There is an inverse relationship between reduced activities of antioxidants (SOD 
and GPx) and increased lipid peroxidation products in blood and CVD 
(Kalenikova et al. 2004).  
 
The results from the first study strengthened the finding that canola oil as the only 
dietary fat source reduces the lifespan of SHRSP rats. This study found that 
canola oil ingestion reduced the lifespan of SHRSP rats compared to soybean oil 
following 1% NaCl loading, 85.8 ± 1.1 and 98.3 ± 3.4 days, respectively 
(Papazzo et al. 2011). The results also showed that blood pressure increased over 
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time in both the soybean oil and canola oil groups; however, there was no 
difference found between each diet. In addition, canola oil ingestion reduced 
RBC SOD, GPx and catalase activities, total cholesterol and LDL-C compared 
with soybean oil. There were no significant differences in RBC MDA 
concentration between canola oil fed and soybean oil fed rats. In contrast, plasma 
MDA concentration and 8-isoprostane were significantly lower in the canola oil 
group compared to the soybean oil group. Also, the plasma 8-isoprostane level in 
the soybean oil group and MDA level in both the canola oil and soybean oil 
groups were higher than the pre-treatment group. In addition, NaCl loading was 
used in this lifespan study to accelerate the development of hypertension. 
However, salt loading may have been masking the effects of canola oil ingestion 
in SHRSP rats. Therefore, the second study was carried out to determine the 
effect of short-term (25 days) ingestion of canola oil in the absence or presence of 
excess dietary salt on oxidative stress in the vasculature of SHRSP rats. The 
results from the 25 day study showed that canola oil ingestion in the absence of 
dietary salt decreased the activities of RBC SOD and GPx, and increased both 
total cholesterol and LDL-C compared with soybean oil. However, the 
combination of canola oil and dietary salt intake resulted in an increase in plasma 
MDA and a decrease in LDL-C concentration, NOX2, p22phox, CuZn-SOD, Mn-
SOD and Ec-SOD aortic mRNA expression when compared to canola oil intake 
alone.  
 
The final study was carried out to determine the effect of canola oil ingestion in 
the absence or presence of excess dietary salt for a longer period of time in 
SHRSP rats. Research has shown that endothelial dysfunction is an independent 
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predicator of CVD (Davies 2009). ROS leads to a decrease in NO, resulting in 
endothelial dysfunction (Fortuno et al. 2005). Therefore, the final study examined 
the effect of 50 days of canola oil ingestion on endothelial function and oxidative 
stress in the vasculature of SHRSP rats. The results showed that canola oil intake 
alone increased RBC SOD, total cholesterol, triglycerides, p22
phox
 and NOX2 
mRNA expression, and decreased RBC GPx compared with soybean oil. 
However, canola oil in combination with salt intake increased RBC MDA 
compared to the soybean oil group with salt and to the canola oil only group. In 
addition, canola oil intake with salt lead to an increase in total cholesterol and a 
decrease in plasma MDA compared to the soybean oil group with salt. The results 
also showed that LDL-C was elevated and RBC SOD, catalase, plasma MDA and 
p22
phox
 mRNA expression were reduced in the canola oil group with salt 
compared to the canola oil only group. Furthermore, the canola oil group in 
combination with salt intake had reduced contractile responses to norepinephrine 
compared to the canola oil group without salt. Also, the contractile responses 
were greater in the SHRSP rats fed only canola oil compared to the soybean oil 
only group. The WKY rats had greater contractile responses compared to the 
soybean oil only group and to both the canola oil and soybean oil groups with 
salt. In addition, canola oil ingestion with salt loading showed impaired 
endothelium-dependent vasodilating responses to ACh compared to the canola oil 
group without salt and WKY rats.  
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6.2 Discussion of the major findings 
Canola oil ingestion shortened the lifespan of SHSRP rats compared to soybean 
oil. These results strengthen and support the findings from previous studies. 
Evidence indicates that canola oil intake has an effect on blood pressure in the 
SHRSP rat and its related strains (Natio et al. 2000, 2000b & 2003). However, the 
blood pressure in the canola oil group was not consistently different from soybean 
oil in all three studies. Taken together these results suggest that canola oil intake 
in the presence or absence of salt does not affect blood pressure. Therefore, the 
results indicate that the life shortening effect of canola oil is not directly related to 
an increase in blood pressure over time. This is also supported by other research, 
which has shown no significant change in blood pressure between the canola oil 
and soybean oil groups in SHRSP rats (Huang et al. 1996; Ratnayake et al. 
2000a). Also, the association between salt intake and hypertension is well known 
(Taylor et al. 2011), which is evident in both the 25 day and 50 day studies. Our 
results demonstrated an increase in systolic blood pressure in both the canola oil 
and soybean oil groups with salt compared to the dietary groups without salt at 
the end of the feeding trial.  
 
To our knowledge this is the first study to investigate the effect of canola oil 
intake on measures of antioxidant status and oxidative damage in SHRSP rats. 
The results from the lifespan study in chapter 3 showed that canola oil ingestion 
reduced RBC SOD, GPx and catalase activities compared with soybean oil by 25, 
18 and 31%, respectively. Evidence has shown that in the SHR, the activity of 
RBC GPx and the activity of catalase in the hepatic cytosol were found to be 
reduced (Ohara et al. 2008). In WKY rats, canola oil ingestion increased the 
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activity of SOD and reduced the activity of catalase in the hepatic cytosol (Ohara 
et al. 2009), while an earlier study showed reduced activities of SOD and catalase 
in the hepatic cytosol of WKY rats (Natio et al. 2000d). Our data are largely 
consistent with these findings. Taken together these results indicate that canola oil 
ingestion affects antioxidant enzyme activity in different tissues. The second 
study showed that the ingestion of canola oil for 25 days in the absence of excess 
dietary salt decreased RBC SOD and GPx compared with soybean oil alone. 
Whereas, 50 days of canola oil ingestion in the absence of salt loading increased 
RBC SOD and decreased GPx activity. The decrease in the activity of RBC GPx 
is consistent in both the 25 day and 50 day studies. In the presence of salt, both 
canola oil and soybean oil ingestion for 25 days decreased the activity of GPx 
compared with the soybean oil group without salt. Whereas, 50 days of canola oil 
ingestion in combination with salt intake resulted in a decrease in RBC SOD and 
catalase. The data is consistent with the lifespan study, which showed a decrease 
in RBC SOD and catalase, however, RBC GPx was also reduced. Supporting 
evidence shows that there is an association between reduced antioxidants and 
CVD (Kalenikova et al. 2004). RBCs are under constant exposure to ROS and 
oxidative stress due to their role in transporting oxygen and carbon dioxide, and 
their increased content of heme iron (Cimen 2008). Therefore, the 
oxidative/antioxidant balance can become altered. In addition, previous research 
has shown an inverse relationship between erythrocyte GPx activity and the 
incidence of CVD (Blankenberg et al. 2003). 
  
In the first study, canola oil ingestion decreased the plasma 8-isoprostane and 
MDA concentration when compared to the soybean oil group. These results were 
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unexpected given the canola oil-induced decrease in erythrocyte antioxidant 
enzyme activity. The mechanism to explain the decreased plasma 8-isoprostane 
and MDA concentration despite a decrease in RBC antioxidant enzyme activity is 
currently unknown. However, the plasma 8-isoprostane in the soybean oil and 
MDA in both the canola oil and soybean oil groups was higher than the pre-
treatment group. In a previous study in WKY rats, canola oil ingestion increased 
lipid peroxide levels in the hepatic cytosol (Ohara et al. 2009), while an earlier 
study showed no change in lipid peroxide levels in the hepatic cytosol of SHR 
(Ohara et al. 2008). The increased plasma 8-isoprostane in the soybean oil group 
and MDA concentrations in both dietary groups compared to pre-treatment 
indicates an increased amount of ROS induced lipid peroxidation over time 
independent from the consumption of either canola or soybean oil. In the 
presence of salt, 25 days of canola oil ingestion increased the plasma MDA 
concentration when compared to the canola oil group without salt. In addition, 
RBC MDA concentration was increased in the canola oil and soybean oil groups 
in the presence of salt compared with the non salt groups. The mechanism by 
which canola oil intake in combination with salt induces MDA is currently 
unknown. Whereas, 50 days of canola oil intake together with salt increased RBC 
MDA compared to all the other dietary groups. While plasma MDA was reduced 
in the canola oil group with salt compared to the soybean oil group with salt. This 
result is consistent with the life span study which showed a decrease in plasma 
MDA in the canola oil group compared to soybean oil. A previous study found an 
increase in urine MDA concentration in Sprague-Dawley rats as a result of salt 
intake (Kitiyakara et al. 2003). They found a difference between the low salt 
(0.03%) and normal salt (0.3%) groups, and between the low salt and high salt 
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(6%) groups. In addition, they also found an increase in urine 8-isoprostane levels 
as a result of salt intake. The results from the 25 day and 50 day studies suggest 
that salt intake is having an effect on the concentration of both plasma and RBC 
MDA when in combination with canola oil ingestion, as there were no changes 
observed in the dietary groups without salt intake.    
 
The results from the 25 day study showed that in the presence of salt, canola oil 
ingestion resulted in a decrease in NOX2, p22phox, CuZn-SOD, Mn-SOD and 
Ec-SOD aortic mRNA expression when compared to canola oil intake alone. This 
study shows for the first time that 25 days of canola oil intake with salt reduces 
NADPH oxidase subunits and SOD isoforms in the aorta of SHRSP rats. The 
decrease in the SOD isoforms indicates a reduced ability to eliminate O2ˉ in the 
presence of canola oil and salt. High salt intake (6%) has been shown to reduce 
renal expression of CuZn-SOD and Mn-SOD in Sprague-Dawley rats (Kitiyakara 
et al. 2003). The results from the 50 day study showed that in the absence of salt, 
canola oil ingestion increased p22
phox
 and NOX2 mRNA expression compared 
with soybean oil. Whereas, canola oil ingestion in the presence of salt decreased 
p22
phox
 mRNA expression compared with to the canola oil only group. It appears 
that canola oil ingestion in combination with salt decreases NADPH oxidase 
mRNA expression. The results also showed that canola oil ingestion without salt, 
and both the soybean oil and canola oil groups with salt increased the mRNA 
expression of CuZn-SOD compared to soybean oil alone. The increase in p22
phox
 
and NOX2 mRNA expression suggests an increase in O2ˉ generation as a result of 
canola oil ingestion alone. In addition, the increase in CuZn-SOD in the canola 
oil group without salt may be an adaptive response to an increase in O2ˉ derived 
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from NADPH oxidase. Evidence has shown that O2ˉ generated from NADPH 
oxidase is increased in hypertension (Paravicini & Touyz 2008). In addition, 
Kitiyakara et al. (2003) found that salt intake in Sprague-Dawley rats lead to an 
increase in O2ˉ production. This was accompanied by an increase in renal activity 
and mRNA expression of NOX2 and p47
phox
, and a decrease in CuZn-SOD and 
MnSOD mRNA expression (Kitiyakara et al. 2003). However, in the vasculature, 
there are several other sources of ROS, which include: xanthine oxidase, 
uncoupled nitric oxide synthase, lipoxygenase and the mitochondrial respiratory 
chain (Jiang et al. 2004; Schulz et al. 2011). In the studies, ROS generation may 
be coming from other sources within the vasculature, and requires further 
investigation. Furthermore, it would have been ideal to examine the protein levels 
of the genes of interest. However, there was insufficient protein to carry out the 
western blot analysis. 
 
The results from the lifespan study (Chapter 3) showed that canola oil ingestion 
reduced total cholesterol and LDL-C compared with soybean oil. This data 
supports the health benefits of canola oil intake. Canola oil is considered to 
provide protective cardiovascular effects due to its favourable fatty acid 
composition (Ratnayake et al. 2000b). However, in the absence of salt, 25 days of 
canola oil ingestion increased both total cholesterol and LDL-C compared with 
soybean oil. Whereas, canola oil in combination with dietary salt intake lead to a 
decrease in LDL-C compared with canola oil intake alone. This data is consistent 
with the results from our first study (Chapter 3), which showed that canola oil 
intake decreased LDL-C, as well as total cholesterol. However, the results from 
our 50 day study showed that in the absence of salt, canola oil ingestion increased 
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total cholesterol and triglycerides. These results are consistent with the results 
from the 25 day study, which showed that canola oil intake alone increased total 
cholesterol, as well as LDL-C. In the presence of salt, canola oil increased total 
cholesterol and LDL-C. In addition, the results from the 50 day study also 
showed that soybean oil in the presence of salt increased total cholesterol, LDL-
C, HDL-C and triglycerides compared to soybean oil alone. Evidence has found 
an associated between increased concentrations of plasma total cholesterol, 
triglycerides and LDL-C and the development of CVD such as atherosclerosis 
(Ballantyne et al. 2005). In addition, there is substantial evidence suggesting that 
high salt intake increases the risk of CVD (Harsha et al. 2004). However, some 
studies suggest that low salt intake and its adverse effects on blood lipids can 
have a detrimental effect on CVD risk (Harsha et al. 2004). The mechanisms by 
which salt intake affects the blood lipids are not clear. A study has shown that 
dietary salt restriction from 10g to 2g per day for 5 days in patients with essential 
hypertension significantly increased total cholesterol and LDL-C (Sharma et al. 
1990).   
 
The results from the 50 day study showed that contractile responses to 
norepinephrine were reduced in the canola oil group with salt compared to the 
canola oil only group, indicating smooth muscle cell contractile dysfunction. 
Also, the contractile responses were greater in the SHRSP rats fed only canola oil 
compared to the soybean oil only group. In addition, the WKY rats had greater 
contractile responses compared to the soybean oil only group and to both the 
canola oil and soybean oil groups with salt. These results show that SHRSP rats 
have reduced smooth muscle contractile function; however, the intake of canola 
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oil alone may result in reducing contractile dysfunction. In addition, canola oil 
ingestion with salt loading showed impaired endothelium-dependent vasodilating 
responses to ACh compared to the canola oil group without salt and WKY rats. 
The results suggest that salt intake in combination with canola oil is leading to 
endothelial dysfunction. A study by Natio et al. (2000b) found that in SHR and 
WKY rats, the endothelium-dependent and endothelium-independent vasodilating 
responses to ACh and SNP, respectively, were not different between the canola 
oil and soybean oil groups in each strain following salt loading (Natio et al. 
2000b). These results are consistent with the results found in the present study, as 
there were no changes found in the vasodilating responses to ACh and SNP 
between the canola oil and soybean oil groups with salt. In addition, evidence has 
shown an associated between high salt intake and endothelial dysfunction 
(Bragulat & de la Sierra 2002). The interaction between salt intake and canola oil 
is not clearly understood, however, it appears that canola oil ingestion in 
combination with salt leads to reduced smooth muscle contractile function and 
impaired endothelium-dependent vasorelaxation. 
 
6.3 Study limitations 
There are a number of limitations associated with the thesis studies. The first is 
the question of whether the life shortening effect associated with canola oil 
consumption is specific to SHRSP rats. Canola oil ingestion has been shown to 
increase blood pressure in WKY rats (Natio et al. 2000d), and cause vascular 
lesions in the kidney and elevate plasma lipids in SHR (Ohara et al. 2008a). In 
human populations there is only one published incidence of canola oil being 
associated with the development of disease (Posada de la Paz et al. 2001). Thus, 
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the consumption of canola oil on lifespan needs to be tested in other rat strains 
and even in humans. Also, our studies did not identify the potential toxic 
compound in canola oil that is causing the life shortening effect. Lastly, it would 
have been ideal to examine the aortic protein expression of NOX2, p22
phox
 and 
the SOD isoforms. However, there was insufficient protein from the aortic 
samples to carry out western blot analysis. A maximum of 20 µg of protein was 
able to be used per sample and the protein bands were undetectable. However, 
studies have used 40 to 50 µg of protein to determine the aortic protein expression 
of the NADPH oxidase subunits and SOD isoforms (El-Awady et al. 2011; de 
Moraes et al. 2008; Wand et al. 2007).  
 
6.4 Future directions 
The research findings described in this thesis have raised questions that warrant 
further investigation. The results have shown that canola oil ingestion in the 
absence and presence of salt leads to changes in oxidative status and aortic 
mRNA expression of NADPH oxidase subunits. However, O2
−
 generation was 
not measured directly, and therefore, aortic sections should be stained with 
dihydroethidium (DHE) to determine whether O2
−
 production is enhanced. 
Furthermore, in the vasculature, there are several other sources of ROS, which 
include: xanthine oxidase, uncoupled nitric oxide synthase, lipoxygenase and the 
mitochondrial respiratory chain (Jiang et al. 2004; Schulz et al. 2011). Therefore, 
future studies should examine other sources of ROS. In addition, the results from 
this thesis have shown that canola oil ingestion in combination with salt leads to 
reduced smooth muscle contractile function and impaired endothelium-dependent 
vasorelaxation. It is well established that ROS interacts with endothelial NO, thus 
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decreasing the vasodilating response of blood vessels. Evidence has shown that in 
Sprague-Dawley rats, high salt intake leads to endothelial dysfunction by 
reducing the concentration of NO and eNOS activity (Datla & Griendling 2010). 
Therefore, a future study should measure NO and eNOS activity, as well as 
examine its aortic mRNA and protein expression. Furthermore, endothelial 
dysfunction is characterised by impaired vasodilatory responses, enhanced 
generation of vasoconstricting substances, platelet activation, increased 
expression of adhesion molecules and a proinflammatory and prothrombotic 
phenotype (Cai & Harrison 2000; Chhabra 2009; Savoia et al. 2011). 
Inflammation contributes to vascular remodelling, and in patients with CVD the 
expression and plasma concentrations of inflammatory markers and mediators 
such as interleukin-6, tumour necrosis factor-a and C-reactive protein are elevated 
(Savoia et al. 2011). The results from this thesis have shown that canola oil in 
combination with salt resulted in impaired vasodilatory responses; therefore, 
raising the question as to whether these animals are in a proinflammatory state. 
Hence, future studies should examine the expression and plasma concentrations 
of inflammatory markers.   
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